<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><?epub September-26-2014?><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id><journal-id journal-id-type="hwp">nar</journal-id><journal-id journal-id-type="publisher-id">nar</journal-id><journal-title-group><journal-title>Nucleic Acids Research</journal-title></journal-title-group><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4231736</article-id><article-id pub-id-type="pmid">25260591</article-id><article-id pub-id-type="doi">10.1093/nar/gku844</article-id><article-categories><subj-group subj-group-type="heading"><subject>RNA</subject></subj-group></article-categories><title-group><article-title>ADAR2 induces reproducible changes in sequence and abundance of mature microRNAs in the mouse brain</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vesely</surname><given-names>Cornelia</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tauber</surname><given-names>Stefanie</given-names></name><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sedlazeck</surname><given-names>Fritz J.</given-names></name><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tajaddod</surname><given-names>Mansoureh</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>von Haeseler</surname><given-names>Arndt</given-names></name><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref><xref ref-type="aff" rid="AFF3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jantsch</surname><given-names>Michael F.</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref><xref ref-type="corresp" rid="COR1">*</xref></contrib><aff id="AFF1"><label>1</label>Department of Chromosome Biology, Max F. Perutz Laboratories, University of Vienna, Dr. Bohr Gasse 9, A-1030 Vienna, Austria</aff><aff id="AFF2"><label>2</label>Center for Integrative Bioinformatics Vienna, Max F. Perutz Laboratories, University of Vienna, Medical University of Vienna, and University of Veterinary Medicine, Dr. Bohr Gasse 9, A-1030 Vienna, Austria</aff><aff id="AFF3"><label>3</label>Bioinformatics and Computational Biology, Faculty of Computer Science, University of Vienna, W&#x000e4;hringer Stra&#x000df;e 29, A-1090 Vienna, Austria</aff></contrib-group><author-notes><corresp id="COR1"><label>*</label>To whom correspondence should be addressed. Tel: +43 1 4277 56230; Fax: +43 1 4277 9562; Email: <email>michael.jantsch@univie.ac.at</email></corresp></author-notes><pub-date pub-type="ppub"><day>29</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>26</day><month>9</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>9</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the							<pub-date pub-type="epub"/>. --><volume>42</volume><issue>19</issue><fpage>12155</fpage><lpage>12168</lpage><history><date date-type="accepted"><day>03</day><month>9</month><year>2014</year></date><date date-type="rev-recd"><day>28</day><month>8</month><year>2014</year></date><date date-type="received"><day>04</day><month>7</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement><copyright-year>2014</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:type="simple" xlink:href="gku844.pdf"/><abstract><p>Adenosine deaminases that act on RNA (ADARs) deaminate adenosines to inosines in double-stranded RNAs including miRNA precursors. A to I editing is widespread and required for normal life. By comparing deep sequencing data of brain miRNAs from wild-type and ADAR2 deficient mouse strains, we detect editing sites and altered miRNA processing at high sensitivity. We detect 48 novel editing events in miRNAs. Some editing events reach frequencies of up to 80%. About half of all editing events depend on ADAR2 while some miRNAs are preferentially edited by ADAR1. Sixty-four percent of all editing events are located within the seed region of mature miRNAs. For the highly edited miR-3099, we experimentally prove retargeting of the edited miRNA to novel 3&#x02032; UTRs. We show further that an abundant editing event in miR-497 promotes processing by Drosha of the corresponding pri-miRNA. We also detect reproducible changes in the abundance of specific miRNAs in ADAR2-deficient mice that occur independent of adjacent A to I editing events. This indicates that ADAR2 binding but not editing of miRNA precursors may influence their processing. Correlating with changes in miRNA abundance we find misregulation of putative targets of these miRNAs in the presence or absence of ADAR2.</p></abstract><counts><page-count count="14"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>29 October 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="SEC1"><title>INTRODUCTION</title><p>Post-transcriptional A to I editing of RNAs is catalyzed by adenosine deaminases that act on RNAs (ADARs). They convert adenosines into inosines in double-stranded RNA structures by hydrolytic deamination. Mammals have three isoforms of ADARs designated as ADAR1 (also known as ADAR), ADAR2 (also known as ADARB1) and ADAR3 (also known as ADARB2). ADAR3, which is predominantly expressed in the brain, is considered to be enzymatically inactive as it has no known editing substrates (<xref rid="B1" ref-type="bibr">1</xref>). Besides the catalytic deaminase domain, ADARs have two to three double-stranded RNA binding domains (dsRBDs) by which they bind double-stranded or structured RNAs. dsRBDs show little sequence preference but can specifically position themselves on certain structures such as terminal loops (<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B3" ref-type="bibr">3</xref>). Consequently, ADARs can do both, promiscuously edit some perfect double-stranded substrates like inverted repeats and function site specifically, as found in some coding RNA targets (<xref rid="B1" ref-type="bibr">1</xref>). As inosine is interpreted as guanosine (G) by most cellular machineries, editing can lead to mRNA recoding (<xref rid="B4" ref-type="bibr">4</xref>). Moreover, editing can also alter the stability of the edited RNA or change its secondary structure. In mammals, ADAR1 and ADAR2 are essential proteins. <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> knockout mice die 20 days after birth with strong epileptic seizures. This phenotype can be rescued by expression of a pre-edited version of glutamate receptor subunit B (GRIA2, also known as GluA2) suggesting that <italic>Gria2</italic> is the most relevant target of ADAR2 (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>). ADAR1 deficient mice, in contrast, die embryonically, show a high interferon signature, increased apoptosis and hematopoietic defects (<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B9" ref-type="bibr">9</xref>). The exact molecular basis of the ADAR1-dependent lethality is still enigmatic.</p><p>Recent screenings of RNA-Seq data have led to the discovery of a large number of editing events (<xref rid="B10" ref-type="bibr">10</xref>&#x02013;<xref rid="B14" ref-type="bibr">14</xref>). While some of these editing events affect coding regions of mRNAs, the majority are found in non-coding regions of mRNAs and in non-coding RNAs (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B15" ref-type="bibr">15</xref>). Moreover, microRNA (miRNA) precursors are a prominent target for editing by ADARs as their stable stem-loop like structures provide good binding sites for dsRBDs (<xref rid="B16" ref-type="bibr">16</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>).</p><p>Primary (pri)-miRNAs are typically transcribed by polymerase II and processed in a two-step process. First, the Drosha-DGCR8 microprocessor cleaves pri-miRNAs in the cell nucleus resulting in the production of 60&#x02013;70-nucleotide-long precursor (pre)-miRNAs. After nuclear export by Exportin-5, the pre-miRNAs are further processed by Dicer-1 to give rise to 20&#x02013;23-nucleotide-long mature miRNAs. Mature miRNAs are finally incorporated into the RNA-induced silencing complex (RISC), mediating a block in translation or degradation of base complementary mRNAs (<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B20" ref-type="bibr">20</xref>). mRNA target recognition mainly occurs via base pairing with the so-called &#x02018;seed sequence&#x02019; located between nucleotides 2 and 8 of the mature miRNA (<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>).</p><p>Previous work has shown that editing of pri-miRNAs can interfere with their processing by either Drosha or Dicer-1. Moreover, the presence of multiple inosines can also lead to the degradation of miRNA precursors by Tudor-SN (<xref rid="B24" ref-type="bibr">24</xref>&#x02013;<xref rid="B26" ref-type="bibr">26</xref>). Editing in the seed sequence of miR-376 can also inhibit their targeting or lead to their retargeting to novel substrates (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B27" ref-type="bibr">27</xref>). Interestingly, miRNA processing can be affected by ADARs independent of their A to I editing activity (<xref rid="B28" ref-type="bibr">28</xref>). This notion is in agreement with the finding that in the mouse many miRNAs are deregulated in the absence of ADARs even if they appear not edited (<xref rid="B29" ref-type="bibr">29</xref>). Similarly, a strong effect of ADARs on miRNA abundance despite low editing levels was observed in <italic>Caenorhabditis elegans</italic>, showing that an editing-independent effect of ADARs on miRNA abundance is conserved from nematodes to mammals (<xref rid="B30" ref-type="bibr">30</xref>). These indirect effects of ADARs on miRNA expression may be caused by binding of the double-stranded structures in miRNA precursors. Moreover, ADAR1 was also found to stimulate DICER activity, thereby providing another mechanism that may affect miRNA levels (<xref rid="B31" ref-type="bibr">31</xref>).</p><p>Previously, we found that the abundance of many miRNAs changes, independent of their editing status in ADAR knockout mouse embryos. Here, ADARB1 (ADAR2) had the strongest effect on miRNA abundance (<xref rid="B29" ref-type="bibr">29</xref>). However, in early embryos editing activity on miRNAs and other substrates is generally low but increases during development (<xref rid="B18" ref-type="bibr">18</xref>). In the present study, we therefore wanted to determine the impact of ADAR2 on the abundance and sequence of mature miRNAs at a later developmental stage. For this purpose, we applied next-generation sequencing to adult brain of wild-type and <italic>AdarB1<sup>&#x02212;/&#x02212;</sup></italic> mice both carrying the pre-edited <italic>Gria<sup>R/R</sup></italic> allele that rescues <italic>AdarB1</italic><sup>&#x02212;/&#x02212;</sup> lethality. Comparison of the miRNA profile of sibling mice of both genotypes allowed us to detect both changes in mature miRNA abundance and A to I editing in mature miRNAs at high sensitivity.</p></sec><sec sec-type="materials|methods" id="SEC2"><title>MATERIALS AND METHODS</title><sec id="SEC2-1"><title>Mice</title><p>The <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> knockout mouse was a kind gift of Peter Seeburg (<xref rid="B5" ref-type="bibr">5</xref>). These transgenic mice are in an SV129 background. As ADAR2 deficiency leads to early postnatal lethality, the mice were rescued with a pre-edited Gria2 receptor (<italic>Gria2<sup>R/R</sup></italic>) (<xref rid="B6" ref-type="bibr">6</xref>). Mice were bred in our facility animal house. <italic>Gria2<sup>R/R</sup>; AdarB1<sup>+/&#x02212;</sup></italic> were intercrossed. The resulting sibling female offspring of genotype <italic>Gria2<sup>R/R</sup>; AdarB<sup>&#x02212;/&#x02212;</sup></italic> and <italic>Gria2<sup>R/R</sup>; AdarB1<sup>+/+</sup></italic> was euthanized at the age of 5.5 months. Whole brain was dissected and subsequently used for RNA preparation from three biological replicates (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B8" ref-type="bibr">8</xref>).</p></sec><sec id="SEC2-2"><title>RNA extraction and miRNA cloning</title><p>Female mouse whole brain was dissected at the age of 5.5 month, homogenized and total RNA was extracted using TriFast reagent according to manufacturer's instructions (PEQLAB Biotechnologie GmbH, Erlangen, Germany). miRNA library preparation was performed as previously described (<xref rid="B29" ref-type="bibr">29</xref>).</p></sec><sec id="SEC2-3"><title>Sequencing and clipping of reads</title><p>Completed libraries were quantified with the Agilent Bioanalyzer dsDNA 1000 assay kit and Agilent QPCR NGS library quantification kit. Cluster generation and sequencing was carried out using the Illumina Genome Analyzer IIx system according to the manufacturer's guidelines. Illumina sequencing was performed at the CSF NGS Unit (csf.ac.at). After sequencing at a read length of 36 base pairs, adaptor sequences were removed using Cutadapt (<xref rid="B32" ref-type="bibr">32</xref>).</p></sec><sec id="SEC2-4"><title>Mapping to mature miRNA sequences</title><p>Mapping of clipped reads to mature miRNA sequences was performed as described (see Manuscript: Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs (<xref rid="B29" ref-type="bibr">29</xref>)). Mapping was performed using NextGenMap, restricting the mapped reads to have at least 90% identity (# differences/alignment length) (<xref rid="B33" ref-type="bibr">33</xref>).</p></sec><sec id="SEC2-5"><title>Identification of significant editing events</title><p>Identification of significant editing events was performed as described (<xref rid="B29" ref-type="bibr">29</xref>). Briefly, a &#x003c7;<sup>2</sup> test was used to identify putative editing events. Because A-to-G editing events are of interest, the test was applied for each A in the mature miRNA sequences taken from miRBase. The number of expected A's was estimated by the overall perfect match rate over all alignments. The number of expected G's was estimated by the number of observed substitutions (besides A to G) over all alignments. The multiple tests problem was addressed by using Benjamini and Hochberg's method &#x02018;fdr&#x02019; (<xref rid="B34" ref-type="bibr">34</xref>). Events that were significant in at least two out of three replicates were considered as relevant and used for further analysis.</p><p>Identification of T-to-C editing events was done analogously. Here, however, the overall mismatch rate was approximated by the sequencing error rate (0.001). To determine significance levels for editing events, the reads for each miRNA were normalized to the total read counts per sequencing lane, prior to performing statistical analysis.</p></sec><sec id="SEC2-6"><title>Cell culture</title><p>U2OS and Hek293 cell lines were grown in Dulbecco's modified Eagle's medium (DMEM) (Lonza) with 10% fetal bovine serum (FBS), 100-U/ml penicillin and 0.1-mg/ml streptomycin. Cells were cultured at 37&#x000b0;C in a 5% CO<sub>2</sub> incubator with humidified air. Mouse embryonic fibroblasts (MEFs) were isolated from ADAR1<sup>&#x02212;/&#x02212;</sup>, ADAR2<sup>&#x02212;/&#x02212;</sup> embryos at day e11.5 and cultured in DMEM supplemented with 20% FBS. A cell line was established by knocking down p53 using plasmid-delivered shRNA (<xref rid="B35" ref-type="bibr">35</xref>).</p></sec><sec id="SEC2-7"><title>Reverse trascriptase-quantitative polymerase chain reaction (RT-qPCR)</title><p>For the quantification of <italic>Npas4</italic>, total RNA prepared for RNASeq was DNase I digested (Fermentas 1 U/&#x003bc;l, 10 U) and reverse transcribed using M-MLV Reverse Transcriptase (Thermo Scientific) and random hexamers in a total volume of 20 &#x003bc;l. Real-time polymerase chain reaction (PCR) was performed on a Bio-Rad iQ5 mastercycler, using GoTaq SYBR Green qPCR master mix (Promega) and the following primers: <italic>Npas4:</italic> sense 5&#x02032;-TAAGGGAGGGGAGCAACTTT-3&#x02032;, antisense 5&#x02032;-GCCCCTAGGAGTGGAGAACT-3&#x02032;, <italic>&#x003b2;-actin:</italic> sense 5&#x02032;-CTTTGCAGCTCCTTCGTTGC-3&#x02032;, antisense 5&#x02032;ACGATGGAGGGGAATACAGC 3&#x02032;; and the PCR program: 40 cycles of 95&#x000b0;C/15 s, 57.5&#x000b0;C/30 s, 72&#x000b0;C/1 min, preceded by denaturation at 95&#x000b0;C/3 min. The relative difference in expression of <italic>Npas4</italic> was calculated by the &#x00394;&#x00394;<italic>C<sub>t</sub></italic> method using <italic>&#x003b2;-actin</italic> as a reference gene.</p></sec><sec id="SEC2-8"><title>Microarray analysis</title><p>Total RNA of two wild-type and two <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> was isolated as described and sent for microarray analysis to KFB Regensburg. Samples were prepared using Ambion<sup>&#x000ae;</sup> WT Expression Kit and analyzed on an Affymetrix GeneChip (Mus musculus).</p></sec><sec id="SEC2-9"><title>Constructs</title><p><italic>Pri-miRNA constructs</italic>: Roughly 120-nucleotide-long sequences of mmu-pri-mir-3099 and -497 were PCR amplified from total mouse DNA and cloned into pSUPERIOR.neo+gfp using the following primers: mir-3099: 5&#x02032;-GATCAGATCTGAAACCTCAAGCCTGCTGAA-3&#x02032; and 5&#x02032;-GATCAAGCTTAATCCTGCATTCGATGCTCT-3; mir-497: 5&#x02032;-GATCAGATCTCTCTCGACCCACCCCAGT-3&#x02032; and 5&#x02032;-GATCAAGCTTCATCGGTGCCTCCCATAC-3&#x02032;. The change from A to G at editing site in mmu-miR-497*, position 20 was accomplished by PCR site-directed mutagenesis. <italic>Targets of miR-3099</italic>: The regions of the 3&#x02032; untranslated regions (UTRs) of Vcan and Nap1l1 containing the miRNA binding sites were PCR amplified from total mouse DNA and cloned into the pmirGLO Dual-Luciferase miRNA Target Expression Vector (Promega) using the following primers: Nap1l1: 5&#x02032;-GATCGAGCTCGATCAGAACCCAGCCGAGT-3&#x02032; and 5&#x02032;-GATCTCTAGAGCATCCCATGAGAGCTAAAACT-3&#x02032;; Vcan: 5&#x02032;-GATCGAGCTCGCGCTGATCCTTAAAATGGC-3&#x02032; and 5&#x02032;-GATCTCTAGAATTTACATGGCCATCGGTGC3&#x02032;.</p></sec><sec id="SEC2-10"><title>Dual luciferase assay</title><p>To determine luciferase reporter expression, cells were co-transfected in 24-well plates using JetPEI reagent (Polyplus, Illkirch, France) following the manufacturers instruction. After 6 h of transfection, cells were washed and incubated for 24 h prior to lysis and luciferase measurements using the dual luciferase (renilla versus firefly) assay kit from Promega (Madison, WI, USA). Readings for renilla luciferase were normalized to firefly luciferase (expressed from the same vector (pmiRGlo). Experiments were done in at least three biological replicates always measuring three technical replicates.</p></sec><sec id="SEC2-11"><title>Northern blot</title><p>Hek293 cells were transfected using JetPEI reagent (Polyplus, Illkirch, France) following the manufacturer's instruction. After 6 h of transfection, cells were washed and incubated for 24 h prior to RNA extraction using Trifast (peqGOLD <italic>TriFast</italic>, PEQLAB). For northern blot analysis, 10 &#x003bc;g of total RNA were loaded on a 10% PAA gel (8M urea 1x TBE) and separated (for detailed northern blot protocol see (<xref rid="B36" ref-type="bibr">36</xref>)). For detection of pri- and pre-miR-497, the following probe: 5&#x02032;-TTTGGACGTGGCCACAGTGCCG-3&#x02032; (complementary to the loop region of the miRNA) was end-labeled using PNK (Thermo Scientific) and &#x003b3;-ATP[32] according to manufacturer's protocol and hybridized over night at 37&#x000b0;C.</p></sec></sec><sec sec-type="results" id="SEC3"><title>RESULTS</title><sec id="SEC3-1"><title>ADAR2 reproducibly affects abundance of mature miRNAs in the brain</title><p>To determine A to I editing but also changes in relative abundance induced by ADAR2, we isolated small RNAs (19&#x02013;25 nucleotides) from adult <italic>Gria2</italic><sup>R/R</sup> and <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic>, <italic>Gria2</italic><sup>R/R</sup> female mouse brains and subjected them to deep sequencing (The <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic>, Gria2<sup>R/R</sup> mouse strain was a kind gift of the lab of Peter Seeburg, MPI, Heidelberg (<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B8" ref-type="bibr">8</xref>)). We chose to use whole adult brain for our analysis, as editing levels are known to be very high in the nervous system (<xref rid="B27" ref-type="bibr">27</xref>). Different genotypes were picked from siblings from heterozygous crosses. For each genotype and biological replicate one lane on an Illumina Genome Analyzer II was used. On average, 29 million reads were obtained per lane. Of these about 71% were mappable to annotated mature miRNA sequences (release 16 of miRBase (<xref rid="B37" ref-type="bibr">37</xref>), see the Materials and Methods section). Reads were mapped with NextGenMap (<xref rid="B33" ref-type="bibr">33</xref>) using a 90% identity threshold (roughly two mismatches per read) to detect potential editing events. Three independent biological replicates of each genotype were examined for all analyses. After mapping, reads were normalized to total mapped miRNA reads per sample. Of the 1055 mature miRNAs annotated in miRBase (Release 16) on average 605 miRNAs were covered by at least 10 reads in all three biological replicates, allowing a maximum of two mismatches.</p><p>Interestingly, only a very small set of five miRNAs accounted for 48% of the mappable reads (Supplementary Figure S1A). This group of miRNAs consisted of the same members in all replicates and in both genotypes with mmu-miR-378a being most abundant. None of the five most abundant miRNAs showed a significant difference in abundance in the ADAR2-deficient versus wild-type brains (Supplementary Figure S1B and C). Mmu-miR-378a had already been reported by others to be edited (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B38" ref-type="bibr">38</xref>). This miRNA has been shown to promote cell migration in non-small cell lung cancer brain metastasis (<xref rid="B39" ref-type="bibr">39</xref>). Also, in a previous study we detected very low editing of this mmu-miR-378a at embryonic day 11.5 (<xref rid="B29" ref-type="bibr">29</xref>). In the adult brain, we find mmu-miR-378a edited to 6.2% at position 16 (Table <xref ref-type="table" rid="tbl4">4</xref>), verifying that editing efficiency of this miRNA increases during development. The editing position at nucleotide 16 is 6 nucleotides away from the DROSHA cleavage site and therefore this editing event is unlikely to interfere with DROSHA activity. The high abundance of mmu-miR-378a in the brain was surprising as this miRNA has not been reported to be highly expressed in the nervous system. However, we detected high expression levels in three independent replicates. No editing could be found for the other four most abundant miRNAs.</p><table-wrap id="tbl1" position="float"><label>Table 1.</label><caption><title>Top 10 of consistently up- or downregulated mature miRNAs</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4" align="center" content-type="1" rowspan="1">Ten most downregulated miRNAs</th><th colspan="4" align="center" content-type="1" rowspan="1">Ten most upregulated miRNAs</th></tr><tr><th align="left" rowspan="1" colspan="1">mmu-miRNA</th><th align="left" rowspan="1" colspan="1">Fold down in <italic>Adar2</italic><sup>&#x02212;/&#x02212;</sup></th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th><th align="left" rowspan="1" colspan="1">Avg. read number/RPM</th><th align="left" rowspan="1" colspan="1">mmu-miRNA</th><th align="left" rowspan="1" colspan="1">Fold up in <italic>Adar2</italic><sup>&#x02212;/&#x02212;</sup></th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th><th align="left" rowspan="1" colspan="1">Avg. read number/RPM</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><underline>miR-497*</underline></td><td align="left" rowspan="1" colspan="1">&#x02212;2.59</td><td align="left" rowspan="1" colspan="1">0.0034</td><td align="left" rowspan="1" colspan="1">2173/104</td><td align="left" rowspan="1" colspan="1"><underline>miR-335-5p</underline></td><td align="left" rowspan="1" colspan="1">2.76</td><td align="left" rowspan="1" colspan="1">0.0841</td><td align="left" rowspan="1" colspan="1">16070/772</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-1247*</td><td align="left" rowspan="1" colspan="1">&#x02212;1.59</td><td align="left" rowspan="1" colspan="1">0.0027</td><td align="left" rowspan="1" colspan="1">155/7</td><td align="left" rowspan="1" colspan="1">miR-15b</td><td align="left" rowspan="1" colspan="1">2.46</td><td align="left" rowspan="1" colspan="1">0.0941</td><td align="left" rowspan="1" colspan="1">124/6</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-1298*</td><td align="left" rowspan="1" colspan="1">&#x02212;1.55</td><td align="left" rowspan="1" colspan="1">0.0492</td><td align="left" rowspan="1" colspan="1">3463/166</td><td align="left" rowspan="1" colspan="1"><underline>miR-98</underline></td><td align="left" rowspan="1" colspan="1">2.27</td><td align="left" rowspan="1" colspan="1">0.0986</td><td align="left" rowspan="1" colspan="1">1911/92</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-495*</td><td align="left" rowspan="1" colspan="1">&#x02212;1.54</td><td align="left" rowspan="1" colspan="1">0.0286</td><td align="left" rowspan="1" colspan="1">267/13</td><td align="left" rowspan="1" colspan="1">miR-467a*</td><td align="left" rowspan="1" colspan="1">2.07</td><td align="left" rowspan="1" colspan="1">0.0311</td><td align="left" rowspan="1" colspan="1">266/13</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-99b</td><td align="left" rowspan="1" colspan="1">&#x02212;1.54</td><td align="left" rowspan="1" colspan="1">0.031</td><td align="left" rowspan="1" colspan="1">167587/8053</td><td align="left" rowspan="1" colspan="1">miR-872*</td><td align="left" rowspan="1" colspan="1">2.01</td><td align="left" rowspan="1" colspan="1">0.0831</td><td align="left" rowspan="1" colspan="1">160/8</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-126-5p</td><td align="left" rowspan="1" colspan="1">&#x02212;1.48</td><td align="left" rowspan="1" colspan="1">0.0604</td><td align="left" rowspan="1" colspan="1">85213/4095</td><td align="left" rowspan="1" colspan="1"><underline>miR-467d*</underline></td><td align="left" rowspan="1" colspan="1">1.92</td><td align="left" rowspan="1" colspan="1">0.0364</td><td align="left" rowspan="1" colspan="1">1033/50</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-128-1*</td><td align="left" rowspan="1" colspan="1">&#x02212;1.44</td><td align="left" rowspan="1" colspan="1">0.0023</td><td align="left" rowspan="1" colspan="1">1636/79</td><td align="left" rowspan="1" colspan="1"><underline>miR-540-5p</underline></td><td align="left" rowspan="1" colspan="1">1.9</td><td align="left" rowspan="1" colspan="1">0.0475</td><td align="left" rowspan="1" colspan="1">887/43</td></tr><tr><td align="left" rowspan="1" colspan="1"><underline>miR-376a*</underline></td><td align="left" rowspan="1" colspan="1">&#x02212;1.44</td><td align="left" rowspan="1" colspan="1">0.0707</td><td align="left" rowspan="1" colspan="1">7035/338</td><td align="left" rowspan="1" colspan="1">miR-337-3p</td><td align="left" rowspan="1" colspan="1">1.89</td><td align="left" rowspan="1" colspan="1">0.0178</td><td align="left" rowspan="1" colspan="1">139/7</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-129-5p</td><td align="left" rowspan="1" colspan="1">&#x02212;1.43</td><td align="left" rowspan="1" colspan="1">0.0805</td><td align="left" rowspan="1" colspan="1">25055/1204</td><td align="left" rowspan="1" colspan="1">miR-3107</td><td align="left" rowspan="1" colspan="1">1.88</td><td align="left" rowspan="1" colspan="1">0.0178</td><td align="left" rowspan="1" colspan="1">1657/80</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-1937a</td><td align="left" rowspan="1" colspan="1">&#x02212;1.42</td><td align="left" rowspan="1" colspan="1">0.0257</td><td align="left" rowspan="1" colspan="1">223/11</td><td align="left" rowspan="1" colspan="1">miR-486</td><td align="left" rowspan="1" colspan="1">1.88</td><td align="left" rowspan="1" colspan="1">0.0178</td><td align="left" rowspan="1" colspan="1">1657/80</td></tr></tbody></table><table-wrap-foot><fn id="TFN001"><p>Only miRNAs with a minimum of 1.3-fold up-or downregulation were considered (Students <italic>t</italic>-test: <italic>P</italic> &#x0003c; 0.1). Underlined miRNAs were found edited in this study. A complete list of up- or downregulated miRNAs can be found in Supplementary Table S1.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table 2.</label><caption><title>Edited miRNAs showing consistent up- or downregulation</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Edited miRNA</th><th align="left" rowspan="1" colspan="1">Abundance fold change in <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic></th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th><th align="left" rowspan="1" colspan="1">Avg. read number/RPM</th><th align="left" rowspan="1" colspan="1">% editing in WT</th><th align="left" rowspan="1" colspan="1">Editing position</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">miR-497*</td><td align="left" rowspan="1" colspan="1">&#x02212;2.59</td><td align="left" rowspan="1" colspan="1">0.0034</td><td align="left" rowspan="1" colspan="1">2173/104</td><td align="left" rowspan="1" colspan="1">73.2</td><td align="left" rowspan="1" colspan="1">20</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-376a*</td><td align="left" rowspan="1" colspan="1">&#x02212;1.44</td><td align="left" rowspan="1" colspan="1">0.0707</td><td align="left" rowspan="1" colspan="1">7035/338</td><td align="left" rowspan="1" colspan="1">58.5</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-99b*</td><td align="left" rowspan="1" colspan="1">&#x02212;1.39</td><td align="left" rowspan="1" colspan="1">0.0201</td><td align="left" rowspan="1" colspan="1">4294/206</td><td align="left" rowspan="1" colspan="1">15.4</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-151-3p</td><td align="left" rowspan="1" colspan="1">&#x02212;1.31</td><td align="left" rowspan="1" colspan="1">0.0548</td><td align="left" rowspan="1" colspan="1">189662/9113</td><td align="left" rowspan="1" colspan="1">2.8</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-873</td><td align="left" rowspan="1" colspan="1">1.3</td><td align="left" rowspan="1" colspan="1">0.0876</td><td align="left" rowspan="1" colspan="1">1155/55</td><td align="left" rowspan="1" colspan="1">1.3</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-467c</td><td align="left" rowspan="1" colspan="1">1.32</td><td align="left" rowspan="1" colspan="1">0.0989</td><td align="left" rowspan="1" colspan="1">209/10</td><td align="left" rowspan="1" colspan="1">48.2</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-669c</td><td align="left" rowspan="1" colspan="1">1.45</td><td align="left" rowspan="1" colspan="1">0.0094</td><td align="left" rowspan="1" colspan="1">248/12</td><td align="left" rowspan="1" colspan="1">3.9</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-467a</td><td align="left" rowspan="1" colspan="1">1.56</td><td align="left" rowspan="1" colspan="1">0.0796</td><td align="left" rowspan="1" colspan="1">874/42</td><td align="left" rowspan="1" colspan="1">9.2</td><td align="left" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-376b</td><td align="left" rowspan="1" colspan="1">1.72</td><td align="left" rowspan="1" colspan="1">0.0806</td><td align="left" rowspan="1" colspan="1">735/35</td><td align="left" rowspan="1" colspan="1">45.4</td><td align="left" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-467d</td><td align="left" rowspan="1" colspan="1">1.83</td><td align="left" rowspan="1" colspan="1">0.0546</td><td align="left" rowspan="1" colspan="1">3711/178</td><td align="left" rowspan="1" colspan="1">1.1/15.2</td><td align="left" rowspan="1" colspan="1">2/3</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-467e</td><td align="left" rowspan="1" colspan="1">1.83</td><td align="left" rowspan="1" colspan="1">0.0435</td><td align="left" rowspan="1" colspan="1">256/12</td><td align="left" rowspan="1" colspan="1">2.1/26.3</td><td align="left" rowspan="1" colspan="1">3/4</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-540-5p</td><td align="left" rowspan="1" colspan="1">1.9</td><td align="left" rowspan="1" colspan="1">0.0475</td><td align="left" rowspan="1" colspan="1">887/43</td><td align="left" rowspan="1" colspan="1">12.1/2.4</td><td align="left" rowspan="1" colspan="1">3/9</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-467d*</td><td align="left" rowspan="1" colspan="1">1.92</td><td align="left" rowspan="1" colspan="1">0.0364</td><td align="left" rowspan="1" colspan="1">1033/50</td><td align="left" rowspan="1" colspan="1">0.8/4.8</td><td align="left" rowspan="1" colspan="1">5/9</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-98</td><td align="left" rowspan="1" colspan="1">2.27</td><td align="left" rowspan="1" colspan="1">0.0986</td><td align="left" rowspan="1" colspan="1">1911/92</td><td align="left" rowspan="1" colspan="1">1.2/0.6</td><td align="left" rowspan="1" colspan="1">11/17</td></tr><tr><td align="left" rowspan="1" colspan="1">miR-335-5p</td><td align="left" rowspan="1" colspan="1">2.76</td><td align="left" rowspan="1" colspan="1">0.0841</td><td align="left" rowspan="1" colspan="1">16070/772</td><td align="left" rowspan="1" colspan="1">1.5</td><td align="left" rowspan="1" colspan="1">4</td></tr></tbody></table><table-wrap-foot><fn id="TFN002"><p>Only edited miRNAs with a minimum of 1.3-fold up-or downregulation were considered (Students <italic>t</italic>-test: <italic>P</italic> &#x0003c; 0.1).</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl3" position="float"><label>Table 3.</label><caption><title>Significantly deregulated mRNAs in <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> brain (<italic>P</italic>-value &#x0003c;0.05)</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Name</th><th align="left" rowspan="1" colspan="1">Fold change</th><th align="left" rowspan="1" colspan="1"><italic>P</italic>-value</th><th align="left" rowspan="1" colspan="1">Description</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Prl</td><td align="left" rowspan="1" colspan="1">17.3</td><td align="left" rowspan="1" colspan="1">0.03682</td><td align="left" rowspan="1" colspan="1">Prolactin</td></tr><tr><td align="left" rowspan="1" colspan="1">Snora16a</td><td align="left" rowspan="1" colspan="1">2.8</td><td align="left" rowspan="1" colspan="1">0.03165</td><td align="left" rowspan="1" colspan="1">Small nucleolar RNA, H/ACA box 16A</td></tr><tr><td align="left" rowspan="1" colspan="1">snoRNA</td><td align="left" rowspan="1" colspan="1">2.7</td><td align="left" rowspan="1" colspan="1">0.00763</td><td align="left" rowspan="1" colspan="1">Mus musculus clone MBI-31 H/ACA box snoRNA, partial sequence</td></tr><tr><td align="left" rowspan="1" colspan="1">snRNA</td><td align="left" rowspan="1" colspan="1">2.6</td><td align="left" rowspan="1" colspan="1">0.00732</td><td align="left" rowspan="1" colspan="1">ncrna: snRNA chromosome:NCBIM37:15:89884840:89884946:-1</td></tr><tr><td align="left" rowspan="1" colspan="1">Snora17</td><td align="left" rowspan="1" colspan="1">2.5</td><td align="left" rowspan="1" colspan="1">0.02595</td><td align="left" rowspan="1" colspan="1">Small nucleolar RNA, H/ACA box 17</td></tr><tr><td align="left" rowspan="1" colspan="1">Name</td><td align="left" rowspan="1" colspan="1">Fold change</td><td align="left" rowspan="1" colspan="1"><italic>P</italic>-value</td><td align="left" rowspan="1" colspan="1">Description</td></tr><tr><td align="left" rowspan="1" colspan="1">Adarb1</td><td align="left" rowspan="1" colspan="1">&#x02212;2.7</td><td align="left" rowspan="1" colspan="1">0.00557</td><td align="left" rowspan="1" colspan="1">Adenosine deaminase, RNA-specific, B1</td></tr><tr><td align="left" rowspan="1" colspan="1">Serpinb1a</td><td align="left" rowspan="1" colspan="1">&#x02212;2.0</td><td align="left" rowspan="1" colspan="1">0.01642</td><td align="left" rowspan="1" colspan="1">Serine (or cysteine) peptidase inhibitor, clade B, member 1a</td></tr><tr><td align="left" rowspan="1" colspan="1">Mir9-2</td><td align="left" rowspan="1" colspan="1">&#x02212;2.0</td><td align="left" rowspan="1" colspan="1">0.01149</td><td align="left" rowspan="1" colspan="1">MicroRNA 9-2</td></tr><tr><td align="left" rowspan="1" colspan="1">Npas4</td><td align="left" rowspan="1" colspan="1">&#x02212;2.0</td><td align="left" rowspan="1" colspan="1">0.01874</td><td align="left" rowspan="1" colspan="1">Neuronal PAS domain protein 4</td></tr></tbody></table><table-wrap-foot><fn id="TFN003"><p>Results of a whole genome microarray analysis of wild-type and <italic>Adar2</italic><sup>&#x02212;/&#x02212;</sup> mouse brain. Only deregulated mRNAs with a <italic>P</italic>-value &#x0003c;0.05 are shown.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl4" position="float"><label>Table 4.</label><caption><title>Significant editing events detected in miRNAs in all three replicates</title></caption><graphic xlink:href="gku844tbl1"/></table-wrap><p>The subsequent analysis of changes in miRNA abundance between wild-type and ADAR2 knockout mice was restricted to the 455 miRNAs that are at least covered by 100 reads in each sequencing replicate, to stay biologically relevant. From these miRNAs 67 showed a consistent change in abundance in brains of <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic>-deficient animals in all three replicates. Of these, 17 miRNAs (26%) were downregulated and 37 miRNAs (56%) upregulated by at least 1.3-fold (Figure <xref ref-type="fig" rid="F1">1</xref>). The remaining 13 miRNAs with changes smaller than 1.3-fold were not considered further. Thus, two times more mature miRNAs show upregulation than downregulation in <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> brains. The highest change in abundance was 2.76-fold up for miR-335-5p and &#x02212;2.59-fold down for miR-497* (Table <xref ref-type="table" rid="tbl1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1.</label><caption><p>miRNAs are consistently up- or downregulated in <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> mice, independent of their editing status. miRNAs with a read coverage greater than 100 reads were sorted according to their relative abundance to wild type (displayed as% of wild-type abundance) in the ADAR2 knockout genotype and plotted on a semi-logarithmic scale. In blue and red are unedited and edited miRNAs, respectively. Wild-type expression level is represented by 100, and a threshold of 1.3-fold deregulation is marked by thin lines. miRNAs with relative changes in abundance smaller than 1.15-fold are not displayed. For a complete list of all consistently deregulated miRNAs see Table <xref ref-type="table" rid="tbl1">1</xref> and Supplementary Table S1.</p></caption><graphic xlink:href="gku844fig1"/></fig><p>Thus, in total we find &#x0223c;8% of all miRNAs expressed in the adult brain to be upregulated in the absence of ADAR2. A complete list of up- and downregulated miRNAs in the brain is shown in Supplementary Table S1.</p><p>It has been reported for some miRNAs that editing near a processing site can lead to a change in processing efficiency of the miRNA (<xref rid="B24" ref-type="bibr">24</xref>&#x02013;<xref rid="B26" ref-type="bibr">26</xref>). Thus, if editing interferes with processing, one would expect a change in abundance of the mature miRNA in the absence of the editing enzyme. Along these lines, we also find edited mature miRNAs among the deregulated miRNAs (Table <xref ref-type="table" rid="tbl2">2</xref>). However, similar to the data from E11.5 embryos also many unedited miRNAs are up- or downregulated in the absence of ADAR2, while many edited miRNAs are not consistently deregulated (compare Figure <xref ref-type="fig" rid="F1">1</xref> and Tables <xref ref-type="table" rid="tbl1">1</xref> and <xref ref-type="table" rid="tbl2">2</xref>) (<xref rid="B29" ref-type="bibr">29</xref>).</p><p>Of the 59 miRNAs that we found edited in our study, only 15 were consistently up- or downregulated by at least 1.3-fold (four miRNAs downregulated, 11 miRNAs upregulated). Additionally, the three most upregulated edited miRNAs show only low editing efficiencies (0.8&#x02013;4.8%) in wild type (Table <xref ref-type="table" rid="tbl2">2</xref>). Together, this argues for an additional editing-independent effect of ADAR2 on processing of miRNAs in the adult brain, most likely by ADAR2 binding to miRNA precursors. Similar findings were made for miRNAs expressed in mouse embryos (<xref rid="B29" ref-type="bibr">29</xref>) and in <italic>C. elegans</italic> (<xref rid="B30" ref-type="bibr">30</xref>).</p><p>Next, we analyzed overall changes in mRNA levels between wild-type and <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> brains using a mouse genome microarray (Affymetrix GeneChip mouse). This analysis showed five significantly upregulated (<italic>P</italic>-value &#x0003c;0.05) and four downregulated genes in the <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> mice (Table <xref ref-type="table" rid="tbl3">3</xref>). Expecting a correlation of the observed deregulated miRNAs and their targets, we looked for overlaps of predicted targets of the most deregulated miRNAs in the ADAR2 mutant within this small set of deregulated mRNAs. We found <italic>Npas4</italic> (downregulated 2-fold) to be a predicted target of the most upregulated miRNA miR-335-5p (2.76-fold upregulation in <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> brain). This mRNA encodes the Neuronal Per Arnt Sim (PAS) Domain Protein 4, NPAS4, a neuron-specific, basic helix&#x02013;loop&#x02013;helix transcription factor that is implicated in hippocampal neurogenesis (<xref rid="B40" ref-type="bibr">40</xref>). In order to validate the result of the microarray analysis, we independently measured <italic>Npas4</italic> mRNA levels by RT-qPCR on brains of wild-type and ADAR2-deficient mice. The RT-qPCR showed a 2.54 &#x000b1; 0.41-fold downregulation of <italic>Npas4</italic> in <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> brains (Supplementary Figure S2; <italic>n</italic> = 3).</p></sec><sec id="SEC3-2"><title>A to G transitions drop significantly in the absence of ADAR2</title><p>A lack of ADAR2 should lead to a decreased number of A to G changes, which reflect A to I editing, in mature miRNAs. However, as the ADAR1 enzyme is still present and active in <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> mice, residual editing by ADAR1 would still be expected. Thus, we analyzed the relative frequency of A to G transitions compared to all other 11 possible nucleotide transition types in wild-type and ADAR2 knockout brains.</p><p>We analyzed mapped reads with maximally two mismatches so that we were able to detect deviations from the annotated miRNA sequences. We also discarded reads that mapped to the reverse complement of the mature miRNAs, as our cloning protocol for mature miRNAs is strand-specific. During mapping, weighting was applied when there were several miRNAs with equally good alignment scores. We considered trimming of the last few nucleotides of the reads as unnecessary, because NextGenMap (<xref rid="B33" ref-type="bibr">33</xref>) computes a local optimal pairwise sequence alignment (<xref rid="B41" ref-type="bibr">41</xref>), which by itself ignores mismatches toward the very end of the read. We recorded the number (0&#x02013;2) and type of mismatches for each read and each position in the mapped read. By doing so a count table of all mismatch types for both genotypes and all three replicates was generated. The occurrence of each mismatch type was normalized by the sum of all mismatches in each biological replicate. This way, we were able to compare the general mismatch profile between wild-type and <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> miRNAs. Although, we detected all 12 possible mismatch types in the mapped reads, the relative frequency of A to G mismatches was the most prevalent one in wild type (Figure <xref ref-type="fig" rid="F2">2</xref>). The number of A to G transitions dropped significantly in the <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> brain to 41% of wild-type level (Students <italic>t</italic>-test <italic>P</italic> &#x0003c; 3.95E&#x02212;05). This strong effect of ADAR2 on the overall A to G transition level of miRNAs demonstrates that ADAR1 only weakly contributes to the observed editing events.</p><fig id="F2" position="float"><label>Figure 2.</label><caption><p>Relative A to G transitions drop significantly in mice deficient in ADAR2. All 12 possible nucleotide transitions in the mapped miRNA reads from wild-type and <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> mice were summed up and normalized to total transition numbers in all three replicates. * Students <italic>t</italic>-test <italic>P</italic> &#x0003c; 0.002.</p></caption><graphic xlink:href="gku844fig2"/></fig><p>Also a second mismatch, namely T to C (which reflects a U to C change in the RNA sequence), showed a genotype-specific difference (Figure <xref ref-type="fig" rid="F2">2</xref>). The number of T to C transitions was increased by 38% in the ADAR2-deficient background (Students <italic>t</italic>-test <italic>P</italic> &#x0003c; 1.45E&#x02212;03). However, when we tested for individual, significant T to C events at specific locations that were present in <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> but not in wild type (see the Materials and Methods section), no single miRNA was detected that showed a significant T to C transition frequency above 1.9%. Overall, only 15 miRNAs showed T to C transitions exclusively in the ADAR2 knockout, most of them with a frequency lower than 0.5% (Supplementary Table S2). Of these 15 miRNAs only mmu-let-7f showed an additional significant A to G change, albeit with a similarly low frequency of 0.42%. It thus appears that T to C transitions are distributed stochastically in the absence of ADAR2.</p><p>The other 10 mismatch types showed no genotype or position specificity and thus were considered as results from sequencing and sample preparation errors.</p></sec><sec id="SEC3-3"><title>High editing levels of mature brain miRNAs influence miRNA processing or targeting</title><p>It is known that editing levels in mRNAs and miRNAs increase during pre- and post-natal development (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B42" ref-type="bibr">42</xref>). Thus, we expected a moderate to high editing frequency of mature miRNAs in adult mouse brains. To determine editing levels of mature miRNAs in wild type, and to reveal possible target specificity of ADAR2 versus ADAR1, we analyzed our data for significant editing events in all miRNAs in the two genotypes. In each biological replicate A to G transitions were counted for individual positions in all miRNAs from wild-type and <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> brains. Using a chi-squared test (see (<xref rid="B29" ref-type="bibr">29</xref>)) an A to G change was assumed significant when the observed number of Gs at that position was higher than expected due to sequencing errors and experimental noise. Only events for which a significant A to G transition was observed in all three replicates were considered for further analysis. Again, only miRNAs covered by at least 100 reads were considered. Doing this, we ended up with a list of 72 significant editing events in 59 miRNAs (Table <xref ref-type="table" rid="tbl4">4</xref>; complete list in Supplementary Table S3).</p><p>The highest editing level is found in mmu-miR-3099 at position 7 of the mature sequence, which is edited to 80% in wild type, and to 66% in ADAR2 mutant brain (Table&#x000a0;<xref ref-type="table" rid="tbl4">4</xref>). miR-3099 has already been found to be edited at this position in other studies (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B38" ref-type="bibr">38</xref>,<xref rid="B43" ref-type="bibr">43</xref>).</p><p>Editing in the seed sequence can lead to retargeting of the miRNA, which was already demonstrated for miR-376a-5p (former miR-376a*) (<xref rid="B27" ref-type="bibr">27</xref>). As miR-3099 is edited up to 80% in the brain, the major amount of this miRNA has the potential to target a different set of mRNAs. Accordingly, the TargetScan Custom algorithm (<ext-link ext-link-type="uri" xlink:href="http://www.targetscan.org/vert_50/seedmatch.html">http://www.targetscan.org/vert_50/seedmatch.html</ext-link>, using default settings) predicts a set of 58 targets for unedited miR-3099, whereas 161 targets are predicted for the edited version, with only three mRNA targets present in both sets.</p><p>As miR-3099 is edited by the essential ADAR1 enzyme (see below) we could not test for changes in the expression of predicted targets in the absence of ADAR1 <italic>in vivo</italic>. Still, to test for a change of target specificity <italic>in vivo</italic> we selected the best target predictions for unedited and edited miR-3099, <italic>Nap1l1</italic> and <italic>Vcan</italic>, respectively and cloned their 3&#x02032;UTRs into the pmiRGlo vector for analysis by dual luciferase assay. Both, the <italic>Nap1l1</italic> and <italic>Vcan</italic> UTRs contain at least one miRNA binding site for the respective miRNA that is conserved from chicken to human. We co-transfected the two different reporter constructs (pmiRGlo + <italic>Nap1l1</italic> or <italic>Vcan</italic> 3&#x02032;UTR) with either unedited or pre-edited pri-miR-3099 or empty vector control (pSuperior-neo-GFP) into human HeK293 cells and measured the effect of the two different miRNA versions on protein expression of the reporters. The <italic>Vcan</italic> 3&#x02032; UTR, the predicted target of edited miR-3099, showed a 44% reduction compared to empty vector control when cotransfected with edited miR-3099 but not with the unedited version. Also the <italic>Nap1l1</italic> 3&#x02032; UTR led to a 24% reduction in the presence of the unedited miRNA but not with the edited form (Figure <xref ref-type="fig" rid="F3">3</xref>). Transfection efficiencies tested by GFP expression from the miRNA expressing pSuperior constructs were &#x0223c;10% for both, edited and unedited miRNA.</p><fig id="F3" position="float"><label>Figure 3.</label><caption><p>Editing of miR-3099 changes its target specificity. (<bold>A</bold>) The 3&#x02032; UTRs of <italic>Nap1l1</italic>&#x02014;target of mmu-miR-3099&#x02014;and <italic>Vcan</italic>&#x02014;target of edited mmu-miR-3099&#x02014;were introduced into pMirGlo downstream of the firefly luciferase open reading frame (ORF). The same plasmid also expresses Renilla luciferase as a reference. (<bold>B</bold>) Relative luciferase activity for the two reporter constructs was measured for the <italic>Vcan</italic> and (<bold>C</bold>) <italic>Nap1l1</italic> harboring plasmids 24 h after cotransfection with control (blue), edited (red) or unedited (green) pri-miR-3099 (<italic>n</italic> = 3). The <italic>Vcan</italic> 3&#x02032;UTR responds to edited miR-3099 while the <italic>Nap1l1</italic> UTR shows a stronger response to unedited miR-3099.</p></caption><graphic xlink:href="gku844fig3"/></fig><p>HeK293 cells show little or no detectable ADAR2 activity. Still ADAR1 activity had been detected in these cells (<xref rid="B44" ref-type="bibr">44</xref>). Therefore, to exclude the possibility that the reporter assay was altered by editing of the transfected pri-miR3099 by ADAR1, the above-mentioned experiments were repeated in immortalized MEFs derived from <italic>Adar1<sup>&#x02212;/&#x02212;</sup></italic>,&#x000a0;<italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> embryos (Supplementary Figure S3). These cells are entirely devoid of all ADAR activity (Vesely, C. and Jantsch, M.F.; personal communication). Still, cotransfection of pre-edited miR-3099 led to an &#x0223c;22% reduction of the <italic>Vcan</italic> reporter while the unedited miR-3099 did not affect reporter gene expression. In contrast, unedited miR-3099 reduced <italic>Nap1|1</italic> reporter gene expression by 30% while the edited version had only reduced gene expression by 14%.</p><p>Taken together these results demonstrate that editing in the seed region strongly redirects miR-3099 from one target to another.</p><p><italic>Vcan</italic> encodes the proteoglycan Versican that stimulates angiogenesis and can promote tumor growth. Consistently, <italic>Vcan</italic> is expressed well during embryogenesis but not in adult tissues. Age- and differentiation-dependent editing of miR-3099 may well be a mechanism repressing <italic>Vcan</italic> expression in adult, differentiated tissues (<xref rid="B45" ref-type="bibr">45</xref>).</p><p>miR-3099 is upregulated during neuro-differentiation and might therefore also play a role in embryogenesis and neuronal function (<xref rid="B46" ref-type="bibr">46</xref>). Using GeneCodis modular and singular enrichment analysis (<ext-link ext-link-type="uri" xlink:href="http://genecodis.cnb.csic.es">http://genecodis.cnb.csic.es</ext-link>, (<xref rid="B47" ref-type="bibr">47</xref>&#x02013;<xref rid="B49" ref-type="bibr">49</xref>)) we looked for enrichment in KEGG pathways in the two sets of predicted targets of miR-3099. The genes potentially targeted by the edited form were enriched for (among others): &#x02018;Glutamatergic synapse&#x02019; (five genes), &#x02018;Axon guidance&#x02019; (four genes) and &#x02018;Notch signaling pathway&#x02019; (three genes), whereas the targets of unedited miR-3099 were not (Supplementary Figure S4). This would be in agreement with a possible requirement of editing of miR-3099 for its proper function in neuro-differentiation.</p><p>The second most edited miRNA was mmu-miR-497* (mmu-miR-497-3p), which is edited to 73% at position 20 in wild type. Interestingly, editing is almost lost in the absence of ADAR2 as the efficiency drops to only 3% in the knockout, indicating that this site is edited almost exclusively by ADAR2. Also mmu-miR-497 is found highly edited (52%) in wild type and almost unedited in <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> (1%). The editing sites, position 20 in miR-497* and position 2 in miR-497, are opposite each other in the double-stranded pre-miRNA structure (Figure <xref ref-type="fig" rid="F4">4A</xref>), suggesting that ADAR2 can edit both sides of the stem loop. However, as we only analyzed mature sequences and not pre-miRNAs we do not know whether the two editing events occur simultaneously or on different molecules. Still given the high frequency of both editing events of 73% and 52%, respectively, some precursor molecules must be edited at both sites simultaneously. Whether this is done by the same ADAR2 molecule or in successive editing reactions is not clear from our data.</p><fig id="F4" position="float"><label>Figure 4.</label><caption><p>Editing of pri-mir-497 enhances its processing efficiency. (<bold>A</bold>) Structure prediction by mfold (<ext-link ext-link-type="uri" xlink:href="http://mfold.rna.albany.edu">http://mfold.rna.albany.edu</ext-link>) for unedited (top) and edited pri-miR-497 (editing at position 74 = position 20 in miR-497*; bottom). Editing sites are marked by yellow circles. Mfold energy predictions of unedited and singly edited pri-miR-497* are indicated. The orange and black straight lines symbolize the mature miRNA sequences while arrows mark the DROSHA cleavage sites. (<bold>B</bold>) Representative northern blot of HEK293 cells transfected with pSuperior expressing unedited (1), pre-edited (2) or no miRNA (3). Processing of pri- to pre-miRNA was analyzed by hybridization with an antisense oligonucleotide. (<bold>C</bold>) Quantification of processing efficiency (ratio pre-miR/pri-miR) from three experiments.</p></caption><graphic xlink:href="gku844fig4"/></fig><p>When pre-mir-497 is edited at position 20 of its star sequence, the precursor stem loop gets stabilized (&#x00394;<italic>G</italic><sub>unedited</sub> = &#x02212;40.2 kcal/mol, &#x00394;<italic>G</italic><sub>497*edited</sub> = &#x02212;48.0 kcal/mol, calculated by mfold, <ext-link ext-link-type="uri" xlink:href="http://mfold.rna.albany.edu">http://mfold.rna.albany.edu</ext-link>, using default setting, (<xref rid="B50" ref-type="bibr">50</xref>)). Editing at position 2 of miR-497 does not change RNA stability compared to the unedited stem loop, and the fully edited version of the pre-miRNA is only slightly less stable than the single editing in 497* alone (&#x00394;<italic>G</italic><sub>fully edited</sub> = &#x02212;47.2 kcal/mol) (Figure <xref ref-type="fig" rid="F4">4A</xref>). Thus, editing of position 20 of miR-497* changes the structure around the DROSHA cleavage site and thereby might enhance DROSHA cleavage efficiency. Confirming this hypothesis, we found miR-497* as the strongest downregulated miRNA (&#x02212;2.6-fold) in ADAR2-deficient brain (see Tables <xref ref-type="table" rid="tbl1">1</xref> and <xref ref-type="table" rid="tbl2">2</xref>).</p><p>To demonstrate the role of editing on pri-mir-497 processing more directly we analyzed the efficiency of the DROSHA cleavage step using Hek293 cells. Wild-type Hek293 cells that show negligible ADAR2 activity were transfected with either unedited or pre-edited (A to G change at position 20 in mmu-miR-497*) primary miRNA and processing efficiencies from pri- to pre-miRNA were analyzed by northern blots (Figure <xref ref-type="fig" rid="F4">4B</xref>). The northern blot shows a 3-fold (+/&#x02212;20%) more efficient processing of edited over unedited pri-mir-497 (Figure <xref ref-type="fig" rid="F4">4C</xref>). This demonstrates that editing of pri-mir-497 by ADAR2 stimulates processing of the primary transcript. pri-miR-497 is edited to 73% in the brain (Table <xref ref-type="table" rid="tbl2">2</xref>). Thus, the 3-fold increase in processing of edited over unedited primiR-497 correlates well with the &#x02212;2.6-fold decrease of the mature miRNA level in the brain upon loss of ADAR2.</p><p>Mature miR-497 is edited to 52% at position 2 within its seed region. TargetSpy (<ext-link ext-link-type="uri" xlink:href="http://www.targetspy.org">www.targetspy.org</ext-link>) predicts the SerpinB1a mRNA to be a strong target (score = 0.995) of the unedited but not the edited miRNA. Consistently, we find SerbinB1 mRNA to be downregulated by &#x0223c;2-fold in the absence of ADAR2 supporting the idea that this mRNA is targeted by unedited miR-497 (Table <xref ref-type="table" rid="tbl3">3</xref>). This finding is even more astonishing when considering that maturation of miR-497 is downregulated upon lack of editing. SerpinB1 is a member of the Serpin family of proteinase inhibitors that protect cells from inflammatory signaling but also regulates cell migration and invasion in gliomas (<xref rid="B51" ref-type="bibr">51</xref>). Moreover, as it was shown that miR-497 regulates neuronal death in mouse brain (<xref rid="B52" ref-type="bibr">52</xref>,<xref rid="B53" ref-type="bibr">53</xref>), editing of this miRNA may play an important role in fine tuning the effect of miR-497 on apoptosis in neuronal cells.</p></sec><sec id="SEC3-4"><title>Half of edited miRNAs in the adult brain are preferentially edited by ADAR2</title><p>To determine editing preferences of the identified sites for ADAR2 or ADAR1, editing levels were also calculated for miRNAs obtained from ADAR2-deficient mouse brains. Interestingly, the editing levels of many miRNAs dropped significantly in the mutant mice. Fifty-one percent of all editing events detected in wild type showed a reduction of editing levels by 50% in <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> brains. In 26% of all sites editing was no longer detectable in the absence of ADAR2 (Table <xref ref-type="table" rid="tbl4">4</xref> and Supplementary Table S3). Also, the six most highly edited miRNAs show a reduction in editing efficiency in the absence of ADAR2. However, in some cases the absence of ADAR2 obviously stimulated editing by ADAR1. Editing levels increased by at least 50% in 11% of all editing events (eight positions in seven miRNAs): miR-376b (position 6), let-7e (positions 17 and 19), miR-381 (position 4), miR-467d* (position 9), miR-3061-3p (position 3), miR-151-3p (position 3), miR-219-3p (position 15). This suggests that binding by ADAR2 can compete for editing by ADAR1 on some miRNA precursors. The data also indicate that ADAR2 and ADAR1 have different preferred pri-miRNA targets and that ADAR2 plays an important role in miRNA editing in the brain.</p></sec><sec id="SEC3-5"><title>Enrichment of editing in the seed region of mature miRNAs</title><p>When examining the positions that showed significant editing events in mature miRNAs, we found that 64% of all editing events occur at position 2&#x02013;7, namely the seed sequence (Figure <xref ref-type="fig" rid="F5">5</xref>). Only 46% of all editing events occur in the remaining 16 positions, if an average length of 22 nucleotides is assumed. This enrichment of editing in the seed sequence shows that ADARs have the potential to play an important role in the modulation of miRNA target specificity in the brain.</p><fig id="F5" position="float"><label>Figure 5.</label><caption><p>Editing events are enriched in the seed sequence of mature miRNAs. The frequencies of all detected editing events within the mature miRNAs (22 nts average length) are plotted in absolute numbers. The distribution of editing events shows a clear preference for the nucleotides 2&#x02013;7, all located within the seed region.</p></caption><graphic xlink:href="gku844fig5"/></fig><p>Looking at the context around editing sites in mature miRNAs we found that a U&#x0003e;A&#x0003e;C&#x0003e;G upstream of the edited A is favored, and downstream ADARs prefer a G&#x0003e;C&#x02248;A&#x0003e;U. The nucleotide opposing the editing site is usually either a C or a U and rarely an A or a G (Supplementary Figure S5). This is in concordance with known editing site preferences (<xref rid="B54" ref-type="bibr">54</xref>,<xref rid="B55" ref-type="bibr">55</xref>).</p></sec><sec id="SEC3-6"><title>New editing sites in mature miRNAs</title><p>Of the 72 detected editing events only one third (<xref rid="B24" ref-type="bibr">24</xref>) had already been published earlier (Supplementary Table S3). Of these, the majority (65%) showed editing levels of more than 5% (see Table <xref ref-type="table" rid="tbl4">4</xref>). Eight newly identified editing events show editing levels of at least 5%. Four of these abundant newly identified events harbor the edited adenosine in the seed region (miR-467c, position 3; miR-467e, position 4; miR-3099, position 2; miR-411, position 2).</p><p>Three of the newly identified editing sites show higher editing levels in the absence of ADAR2 (miR-542-3p, position 16; let-7e, position 19; and miR-574-5p, position 17), showing that these miRNAs are preferentially edited by ADAR1 (Table <xref ref-type="table" rid="tbl4">4</xref>). Increased editing in the absence of ADAR2 also suggests that editing by ADAR1 might be blocked by ADAR2 binding, without editing them. In contrast, editing sites in all other newly identified edited miRNAs, except for position 2 of miR-3099, are significantly less edited in the ADAR2 mutant. This shows that they are preferentially edited by ADAR2 (miR-467c at position 3, miR-467e at position 4, miR-708* at position 21 and miR-411 at position 2) (see Table <xref ref-type="table" rid="tbl4">4</xref>).</p></sec></sec><sec sec-type="discussion" id="SEC4"><title>DISCUSSION</title><p>In this study, we have determined changes in sequence and abundance of mature miRNAs in wild type versus ADAR2 (also known as ADARB1) deficient adult mouse brains. We demonstrate that clear and reproducible changes in the abundance of a set of miRNAs occur in the absence of ADAR2. Variations range from a 2.6-fold downregulation to a 2.8-fold upregulation in the absence of ADAR2. In general, however, loss of ADAR2 leads to a significantly larger proportion of upregulated miRNAs. Similar to previous studies in mouse embryos and in <italic>C. elegans</italic>, deregulation of miRNAs seems independent of RNA editing in the adult brain (<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B30" ref-type="bibr">30</xref>). This is documented by the fact that both unedited miRNAs are found deregulated in the absence of ADAR2, while some highly edited miRNAs show no changes in abundance at all. This finding is in agreement with the idea that binding of ADARs to miRNA precursors or interaction of ADARs with miRNA processing factors can influence miRNA processing without editing. It should be noted, however, that by sequencing mature miRNAs, editing events that are located only in the precursor, outside the mature miRNA, are not detected in our study. Still, as editing events that affect processing should lie within the immediate vicinity of the DROSHA or DICER cleavage sites, it is highly unlikely that all misregulated miRNAs can be attributed to such an event. Moreover, ADARs may also regulate miRNA processing by affecting the expression or activity of components of the miRNA processing machinery. A similar indirect effect was recently described for the impact of ADARs on the control of alternative splicing (<xref rid="B56" ref-type="bibr">56</xref>).</p><p>As miRNAs are important regulators of mRNA translation we can observe reproducible changes in mRNA expression profiles in the absence of ADAR2. For instance, we can detect a strong downregulation of <italic>Npas4</italic> mRNA correlating with miR-335-5p upregulation. This finding nicely underlines the biological relevance of ADAR2-dependent changes in miRNA abundance.</p><p>Compared to our previous study performed in mouse embryos, a smaller number of miRNAs are found to be consistently deregulated in the absence of ADAR2 in the adult brain (<xref rid="B29" ref-type="bibr">29</xref>). As expected, however, we find a larger number of miRNAs edited to a much higher extent in the adult brain than at the early embryo. This is in agreement with published data showing that miRNA editing drastically increases during development (<xref rid="B18" ref-type="bibr">18</xref>). Thus, in contrast to embryos where ADARs mainly affect miRNA abundance, in the adult brain some miRNAs are strongly affected by the actual editing reaction leading to changes in target specificity. As we only consider ADAR2 in this study, it is possible that even more mature miRNAs are affected in an adult ADAR1-deficient brain (<xref rid="B8" ref-type="bibr">8</xref>).</p><p>Currently it is not clear why ADARs interfere more strongly with miRNA abundance but show little editing activity in the early embryo. It is possible, however, that miRNA processing becomes more robust in later developmental stages, therefore becoming less sensitive to competing double-stranded RNA binding proteins.</p><p>Interestingly, editing levels in the 5.5-months-old mice used here were comparable to those previously reported for 21-days-old mice (<xref rid="B18" ref-type="bibr">18</xref>). This suggests that most miRNA editing events reach a plateau upon reaching adulthood.</p><p>A recent study showed that ADAR1 and DICER directly interact and form a more effective miRNA processing complex (<xref rid="B31" ref-type="bibr">31</xref>). In this study, a global downregulation of mature miRNAs in ADAR1 single mutant embryos was observed which was explained by the lack of ADAR1&#x02013;DICER processing complexes (<xref rid="B31" ref-type="bibr">31</xref>). Neither in our previous study in mouse embryos (<xref rid="B29" ref-type="bibr">29</xref>) nor in the current study in the adult brain could we observe such a global downregulation of mature miRNAs in the absence of ADAR2 or both ADAR1 and ADAR2. In contrast, we find more mature miRNAs upregulated relative to wild type in the knockout mice. These apparently conflicting results might be explained by differences in the temporal regulation of miRNA expression during development, where time differences of 0.5&#x02013;1 days can be important. In our study performed in embryos the used ADAR1 knockout mice survive in general at least 0.5 days longer than the strain used by Ota <italic>et&#x000a0;al.</italic> (<xref rid="B31" ref-type="bibr">31</xref>), thus possibly explaining the observed differences (<xref rid="B29" ref-type="bibr">29</xref>). Also, as ADAR2 seemingly does not interact with DICER, loss of ADAR2 may only indirectly affect pre-miRNA processing, possibly via competitive binding.</p><p>Our study shows that the overall number of A to G changes drops almost by 60% in the absence of ADAR2, although ADAR1 is still present. Some editing events seem to exclusively depend on the presence of ADAR2, while others are not affected by this enzyme. This indicates that ADAR2 plays an important role in introducing A to I changes into mature miRNAs and that individual ADARs must display specificity for certain miRNA targets. Given that the overall structure of pri- and pre-miRNAs is relatively similar, this finding is rather surprising. Apparently, enzyme preferences for certain sites in miRNAs are caused by a combination of subtle differences in the substrates.</p><p>We find that editing levels in the adult mouse brain can reach 80%. Thirteen miRNAs show editing levels above 10% within their seed region, which will significantly influence their target specificity. Using a reporter assay we demonstrate that two predicted targets for edited and unedited versions of the most highly edited miRNA, miR-3099, are only affected by the edited and unedited miR-3099, respectively. Interestingly, the two sets of predicted targets for the unedited and edited miRNA isoforms only overlap by three mRNAs. Together this indicates that this particular editing event may lead to dramatic retargeting of miR-3099 in wild-type mice. miR-3099 was identified in a deep sequencing study of the developing mouse brain (<xref rid="B46" ref-type="bibr">46</xref>). Due to its spatiotemporal expression pattern it was suggested to possibly influence neural differentiation or function.</p><p>Another highly edited miRNA, miR-497, that is edited in the seed region and the star sequence to 52% and 73%, respectively, is not only redirected but also downregulated by more than 2.5-fold, upon loss of editing. As we only analyzed mature miRNAs by sequences we cannot state whether both editing events are linked to each other. However, given the high frequency of both editing events at least 30% of all molecules must harbor both editing events. For miR-497, we could show that a pre-edited version is processed more efficiently by DROSHA. Thus, this miRNA is tightly controlled by ADAR2 by both upregulating its processing and redirecting its target specificity. Interestingly, miR-497 has been found to positively regulate neuronal death in mouse brain and target genes like <italic>Bcl-2</italic>, <italic>Bcl-w</italic>, <italic>cyclin D2</italic> and <italic>SerpinB1</italic> therefore underlining the importance for a tight regulation of this miRNA (<xref rid="B52" ref-type="bibr">52</xref>,<xref rid="B53" ref-type="bibr">53</xref>). A similar effect of ADAR editing on processing of polycistronic pri-miRNAs has recently been shown in <italic>Drosophila</italic>, where editing can promote but also inhibit the processing of certain miRNAs (<xref rid="B57" ref-type="bibr">57</xref>). In the absence of ADAR2, we found decreased <italic>SerpinB1</italic> mRNA levels which is predicted to be targeted by the native but not the edited miR-497 underscoring the impact of RNA editing in the seed region of this miRNA.</p><p>Several new editing sites were identified in miRNAs of which four occur in the seed sequence with at least 5% abundance. Of these, miR-467 is edited to 48% in wild type, and hence almost half of the produced miRNAs have the potential to target different mRNAs in wild-type mice. Moreover, besides confirming already published editing sites in miRNAs we could also distinguish editing site preferences of the two enzymes ADAR1 and ADAR2. For example miR-497 is exclusively targeted by ADAR2, whereas miR-376b is edited by ADAR1, as it is even more efficiently edited in the absence of ADAR2. The determined target specificities of ADARs for the edited brain miRNAs will be a valuable basis for future studies on the functional implications of edited miRNAs.</p><p>We also detected a global but significant change of T to C transitions in miRNAs isolated from <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> mice (possibly representing U to C changes in the RNA). However, those changes were stochastically distributed along the length of all miRNAs and not enriched at a specific position. This finding is in good agreement with other studies that have observed similar low-level T to C changes in RNA-Seq experiments (<xref rid="B58" ref-type="bibr">58</xref>,<xref rid="B59" ref-type="bibr">59</xref>). Nonetheless, to understand the occurrence and possible site specificity of these events would require deeper sequencing. Thus, at present, the biological relevance of T to C transitions remains obscure. One possible influence of ADARs on the frequency of T to C transitions could come from editing of the mRNA of DNA repair enzymes and thereby changing their enzymatic properties, like it has been shown for NEIL1 (<xref rid="B60" ref-type="bibr">60</xref>). Still, further studies are needed to understand the T to C changes and the involvement of ADARs in this transition type.</p><p>In summary, our study clearly demonstrates that ADAR2 influences miRNA abundance and targeting at several levels. First, binding of ADAR2 seemingly interferes with miRNA processing, possibly by competitive binding. Second, editing events near Drosha and Dicer cleavage sites can modulate the processing efficiencies of the cognate enzymes. Third, editing in the seed region of mature brain miRNAs can lead to retargeting and therefore diversify miRNA functions in the mammalian brain. Lastly, ADARs may indirectly influence miRNA processing by controlling the expression or activity of other factors involved in the miRNA processing pathway.</p></sec><sec id="SEC5"><title>AVAILABILITY</title><p>Illumina reads for 21&#x02013;23-nt-long RNAs for wild-type and <italic>Adarb1<sup>&#x02212;/&#x02212;</sup></italic>-deficient mice and microarray results are available at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>.</p></sec><sec id="SEC6"><title>ACCESSION NUMBERS</title><p>Accession numbers&#x000a0;for Illumina reads and Affymetrix expresssion data are GSE61068 and are available here <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61068">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61068</ext-link>.</p><p>Illumina reads are available following this link: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61066">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61066</ext-link>.</p><p>Affymetrix mRNA expression data are available following this link : <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61067">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE61067</ext-link>.</p></sec><sec sec-type="supplementary-material" id="SEC7"><title>SUPPLEMENTARY DATA</title><p><ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gku844/-/DC1">Supplementary Data</ext-link> are available at NAR Online.</p>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title>SUPPLEMENTARY DATA</title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_42_19_12155__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="pdf"
xlink:href="supp_gku844_nar-01803-a-2014-File007.pdf"/>
</supplementary-material>
</sec></body><back><ack><p>The authors would like to thank Miya Higuchi and Peter Seeburg (MPI, Heidelberg) for kindly providing <italic>Adar2<sup>&#x02212;/&#x02212;</sup></italic> knockout mice. Illumina deep sequencing was performed at the CSF NGS Unit (csf.ac.at).</p><p><italic>Authors&#x02019; contributions.</italic> C.V. and M.F.J. designed and C.V. carried out the experiments. M.T. helped with quantification of gene expression experiments. C.V. and S.T. did the data analysis in discussion with M.F.J. and A.v.H. C.V. drafted the manuscript, which M.F.J. edited. F.J.S. contributed the mapping of the reads to the miRBase reference and determined editing and expression levels. All authors have read and approved the manuscript for publication.</p></ack><fn-group><fn id="FN1" fn-type="present-address"><p>Present address: Stefanie Tauber, Institute of Molecular Biology, Ackermannweg 4, D-55128 Mainz, Germany.</p></fn></fn-group><sec id="SEC8"><title>FUNDING</title><p>Austrian Science Foundation [F4313 to M.F.J.]; CV was supported by the Doctoral Program W1207, ST and FJS were supported by the Viennese WWTF fund to AvH Funding for open access charge: Austrian Science Foundation Grant [SFB F4313].</p><p><italic>Conflict of interest statement</italic>. None declared.</p></sec><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishikura</surname><given-names>K.</given-names></name></person-group><article-title>Functions and regulation of RNA editing by ADAR deaminases</article-title><source>Annu. Rev. Biochem.</source><year>2010</year><volume>79</volume><fpage>321</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">20192758</pub-id></element-citation></ref><ref id="B2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barraud</surname><given-names>P.</given-names></name><name><surname>Allain</surname><given-names>F.H.</given-names></name></person-group><article-title>ADAR proteins: double-stranded RNA and Z-DNA binding domains</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2012</year><volume>353</volume><fpage>35</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">21728134</pub-id></element-citation></ref><ref id="B3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefl</surname><given-names>R.</given-names></name><name><surname>Oberstrass</surname><given-names>F.C.</given-names></name><name><surname>Hood</surname><given-names>J.L.</given-names></name><name><surname>Jourdan</surname><given-names>M.</given-names></name><name><surname>Zimmermann</surname><given-names>M.</given-names></name><name><surname>Skrisovska</surname><given-names>L.</given-names></name><name><surname>Maris</surname><given-names>C.</given-names></name><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>Hofr</surname><given-names>C.</given-names></name><name><surname>Emeson</surname><given-names>R.B.</given-names></name><etal/></person-group><article-title>The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove</article-title><source>Cell</source><year>2010</year><volume>143</volume><fpage>225</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">20946981</pub-id></element-citation></ref><ref id="B4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connell</surname><given-names>M.A.</given-names></name></person-group><article-title>RNA editing: rewriting receptors</article-title><source>Curr. Biol.</source><year>1997</year><volume>7</volume><fpage>R437</fpage><lpage>R439</lpage><pub-id pub-id-type="pmid">9210370</pub-id></element-citation></ref><ref id="B5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brusa</surname><given-names>R.</given-names></name><name><surname>Zimmermann</surname><given-names>F.</given-names></name><name><surname>Koh</surname><given-names>D.</given-names></name><name><surname>Feldmeyer</surname><given-names>D.</given-names></name><name><surname>Gass</surname><given-names>P.</given-names></name><name><surname>Seeburg</surname><given-names>P.</given-names></name><name><surname>Sprengel</surname><given-names>R.</given-names></name></person-group><article-title>Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice</article-title><source>Science</source><year>1995</year><volume>270</volume><fpage>1677</fpage><lpage>1680</lpage><pub-id pub-id-type="pmid">7502080</pub-id></element-citation></ref><ref id="B6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higuchi</surname><given-names>M.</given-names></name><name><surname>Maas</surname><given-names>S.</given-names></name><name><surname>Single</surname><given-names>F.</given-names></name><name><surname>Hartner</surname><given-names>J.</given-names></name><name><surname>Rozov</surname><given-names>A.</given-names></name><name><surname>Burnashev</surname><given-names>N.</given-names></name><name><surname>Feldmeyer</surname><given-names>D.</given-names></name><name><surname>Sprengel</surname><given-names>R.</given-names></name><name><surname>Seeburg</surname><given-names>P.</given-names></name></person-group><article-title>Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2</article-title><source>Nature</source><year>2000</year><volume>406</volume><fpage>78</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">10894545</pub-id></element-citation></ref><ref id="B7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartner</surname><given-names>J.C.</given-names></name><name><surname>Walkley</surname><given-names>C.R.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Orkin</surname><given-names>S.H.</given-names></name></person-group><article-title>ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling</article-title><source>Nat. Immunol.</source><year>2009</year><volume>10</volume><fpage>109</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">19060901</pub-id></element-citation></ref><ref id="B8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartner</surname><given-names>J.C.</given-names></name><name><surname>Schmittwolf</surname><given-names>C.</given-names></name><name><surname>Kispert</surname><given-names>A.</given-names></name><name><surname>Muller</surname><given-names>A.M.</given-names></name><name><surname>Higuchi</surname><given-names>M.</given-names></name><name><surname>Seeburg</surname><given-names>P.H.</given-names></name></person-group><article-title>Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>4894</fpage><lpage>4902</lpage><pub-id pub-id-type="pmid">14615479</pub-id></element-citation></ref><ref id="B9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Miyakoda</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Khillan</surname><given-names>J.</given-names></name><name><surname>Stachura</surname><given-names>D.L.</given-names></name><name><surname>Weiss</surname><given-names>M.J.</given-names></name><name><surname>Nishikura</surname><given-names>K.</given-names></name></person-group><article-title>Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>4952</fpage><lpage>4961</lpage><pub-id pub-id-type="pmid">14613934</pub-id></element-citation></ref><ref id="B10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.B.</given-names></name><name><surname>Levanon</surname><given-names>E.Y.</given-names></name><name><surname>Yoon</surname><given-names>J.K.</given-names></name><name><surname>Aach</surname><given-names>J.</given-names></name><name><surname>Xie</surname><given-names>B.</given-names></name><name><surname>Leproust</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Church</surname><given-names>G.M.</given-names></name></person-group><article-title>Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing</article-title><source>Science</source><year>2009</year><volume>324</volume><fpage>1210</fpage><lpage>1213</lpage><pub-id pub-id-type="pmid">19478186</pub-id></element-citation></ref><ref id="B11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barak</surname><given-names>M.</given-names></name><name><surname>Levanon</surname><given-names>E.Y.</given-names></name><name><surname>Eisenberg</surname><given-names>E.</given-names></name><name><surname>Paz</surname><given-names>N.</given-names></name><name><surname>Rechavi</surname><given-names>G.</given-names></name><name><surname>Church</surname><given-names>G.M.</given-names></name><name><surname>Mehr</surname><given-names>R.</given-names></name></person-group><article-title>Evidence for large diversity in the human transcriptome created by Alu RNA editing</article-title><source>Nucleic Acids Res.</source><year>2009</year><volume>37</volume><fpage>6905</fpage><lpage>6915</lpage><pub-id pub-id-type="pmid">19740767</pub-id></element-citation></ref><ref id="B12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neeman</surname><given-names>Y.</given-names></name><name><surname>Levanon</surname><given-names>E.Y.</given-names></name><name><surname>Jantsch</surname><given-names>M.F.</given-names></name><name><surname>Eisenberg</surname><given-names>E.</given-names></name></person-group><article-title>RNA editing level in the mouse is determined by the genomic repeat repertoire</article-title><source>RNA</source><year>2006</year><volume>12</volume><fpage>1802</fpage><lpage>1809</lpage><pub-id pub-id-type="pmid">16940548</pub-id></element-citation></ref><ref id="B13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levanon</surname><given-names>E.Y.</given-names></name><name><surname>Eisenberg</surname><given-names>E.</given-names></name><name><surname>Yelin</surname><given-names>R.</given-names></name><name><surname>Nemzer</surname><given-names>S.</given-names></name><name><surname>Hallegger</surname><given-names>M.</given-names></name><name><surname>Shemesh</surname><given-names>R.</given-names></name><name><surname>Fligelman</surname><given-names>Z.Y.</given-names></name><name><surname>Shoshan</surname><given-names>A.</given-names></name><name><surname>Pollock</surname><given-names>S.R.</given-names></name><name><surname>Sztybel</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Systematic identification of abundant A-to-I editing sites in the human transcriptome</article-title><source>Nat. Biotechnol.</source><year>2004</year><volume>22</volume><fpage>1001</fpage><lpage>1005</lpage><pub-id pub-id-type="pmid">15258596</pub-id></element-citation></ref><ref id="B14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazak</surname><given-names>L.</given-names></name><name><surname>Haviv</surname><given-names>A.</given-names></name><name><surname>Barak</surname><given-names>M.</given-names></name><name><surname>Jacob-Hirsch</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Isaacs</surname><given-names>F.J.</given-names></name><name><surname>Rechavi</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>J.B.</given-names></name><name><surname>Eisenberg</surname><given-names>E.</given-names></name></person-group><article-title>A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes</article-title><source>Genome Res.</source><year>2014</year><volume>24</volume><fpage>365</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">24347612</pub-id></element-citation></ref><ref id="B15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogg</surname><given-names>M.</given-names></name><name><surname>Paro</surname><given-names>S.</given-names></name><name><surname>Keegan</surname><given-names>L.P.</given-names></name><name><surname>O'Connell</surname><given-names>M.A.</given-names></name></person-group><article-title>RNA editing by mammalian ADARs</article-title><source>Adv. Genet.</source><year>2011</year><volume>73</volume><fpage>87</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">21310295</pub-id></element-citation></ref><ref id="B16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Lopez</surname><given-names>J.</given-names></name><name><surname>Hourcade Jde</surname><given-names>D.</given-names></name><name><surname>Del Mazo</surname><given-names>J.</given-names></name></person-group><article-title>Reprogramming of microRNAs by adenosine-to-inosine editing and the selective elimination of edited microRNA precursors in mouse oocytes and preimplantation embryos</article-title><source>Nucleic Acids Res.</source><year>2013</year><volume>41</volume><fpage>5483</fpage><lpage>5493</lpage><pub-id pub-id-type="pmid">23571754</pub-id></element-citation></ref><ref id="B17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wulff</surname><given-names>B.E.</given-names></name><name><surname>Nishikura</surname><given-names>K.</given-names></name></person-group><article-title>Modulation of microRNA expression and function by ADARs</article-title><source>Curr. Top. Microbiol. Immunol.</source><year>2012</year><volume>353</volume><fpage>91</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">21761289</pub-id></element-citation></ref><ref id="B18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekdahl</surname><given-names>Y.</given-names></name><name><surname>Farahani</surname><given-names>H.S.</given-names></name><name><surname>Behm</surname><given-names>M.</given-names></name><name><surname>Lagergren</surname><given-names>J.</given-names></name><name><surname>Ohman</surname><given-names>M.</given-names></name></person-group><article-title>A-to-I editing of microRNAs in the mammalian brain increases during development</article-title><source>Genome Res.</source><year>2012</year><volume>22</volume><fpage>1477</fpage><lpage>1487</lpage><pub-id pub-id-type="pmid">22645261</pub-id></element-citation></ref><ref id="B19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group><article-title>MicroRNAs: genomics, biogenesis, mechanism, and function</article-title><source>Cell</source><year>2004</year><volume>116</volume><fpage>281</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">14744438</pub-id></element-citation></ref><ref id="B20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>R.C.</given-names></name><name><surname>Doudna</surname><given-names>J.A.</given-names></name></person-group><article-title>Molecular mechanisms of RNA interference</article-title><source>Annu. Rev. Biophys.</source><year>2013</year><volume>42</volume><fpage>217</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">23654304</pub-id></element-citation></ref><ref id="B21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name></person-group><article-title>Composition of seed sequence is a major determinant of microRNA targeting patterns</article-title><source>Bioinformatics.</source><year>2014</year><volume>30</volume><fpage>1377</fpage><lpage>1383</lpage><pub-id pub-id-type="pmid">24470575</pub-id></element-citation></ref><ref id="B22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>D.W.</given-names></name><name><surname>Bracken</surname><given-names>C.P.</given-names></name><name><surname>Goodall</surname><given-names>G.J.</given-names></name></person-group><article-title>Experimental strategies for microRNA target identification</article-title><source>Nucleic Acids Res.</source><year>2011</year><volume>39</volume><fpage>6845</fpage><lpage>6853</lpage><pub-id pub-id-type="pmid">21652644</pub-id></element-citation></ref><ref id="B23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>B.P.</given-names></name><name><surname>Burge</surname><given-names>C.B.</given-names></name><name><surname>Bartel</surname><given-names>D.P.</given-names></name></person-group><article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets</article-title><source>Cell</source><year>2005</year><volume>120</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">15652477</pub-id></element-citation></ref><ref id="B24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>Y.</given-names></name><name><surname>Zinshteyn</surname><given-names>B.</given-names></name><name><surname>Chendrimada</surname><given-names>T.P.</given-names></name><name><surname>Shiekhattar</surname><given-names>R.</given-names></name><name><surname>Nishikura</surname><given-names>K.</given-names></name></person-group><article-title>RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex</article-title><source>EMBO Rep.</source><year>2007</year><volume>8</volume><fpage>763</fpage><lpage>769</lpage><pub-id pub-id-type="pmid">17599088</pub-id></element-citation></ref><ref id="B25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Chendrimada</surname><given-names>T.P.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Higuchi</surname><given-names>M.</given-names></name><name><surname>Seeburg</surname><given-names>P.H.</given-names></name><name><surname>Shiekhattar</surname><given-names>R.</given-names></name><name><surname>Nishikura</surname><given-names>K.</given-names></name></person-group><article-title>Modulation of microRNA processing and expression through RNA editing by ADAR deaminases</article-title><source>Nat. Struct. Mol. Biol.</source><year>2006</year><volume>13</volume><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">16369484</pub-id></element-citation></ref><ref id="B26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>Y.</given-names></name><name><surname>Megraw</surname><given-names>M.</given-names></name><name><surname>Kreider</surname><given-names>E.</given-names></name><name><surname>Iizasa</surname><given-names>H.</given-names></name><name><surname>Valente</surname><given-names>L.</given-names></name><name><surname>Hatzigeorgiou</surname><given-names>A.G.</given-names></name><name><surname>Nishikura</surname><given-names>K.</given-names></name></person-group><article-title>Frequency and fate of microRNA editing in human brain</article-title><source>Nucleic Acids Res.</source><year>2008</year><volume>36</volume><fpage>5270</fpage><lpage>5280</lpage><pub-id pub-id-type="pmid">18684997</pub-id></element-citation></ref><ref id="B27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>Y.</given-names></name><name><surname>Zinshteyn</surname><given-names>B.</given-names></name><name><surname>Sethupathy</surname><given-names>P.</given-names></name><name><surname>Iizasa</surname><given-names>H.</given-names></name><name><surname>Hatzigeorgiou</surname><given-names>A.G.</given-names></name><name><surname>Nishikura</surname><given-names>K.</given-names></name></person-group><article-title>Redirection of silencing targets by adenosine-to-inosine editing of miRNAs</article-title><source>Science</source><year>2007</year><volume>315</volume><fpage>1137</fpage><lpage>1140</lpage><pub-id pub-id-type="pmid">17322061</pub-id></element-citation></ref><ref id="B28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heale</surname><given-names>B.S.</given-names></name><name><surname>Keegan</surname><given-names>L.P.</given-names></name><name><surname>McGurk</surname><given-names>L.</given-names></name><name><surname>Michlewski</surname><given-names>G.</given-names></name><name><surname>Brindle</surname><given-names>J.</given-names></name><name><surname>Stanton</surname><given-names>C.M.</given-names></name><name><surname>Caceres</surname><given-names>J.F.</given-names></name><name><surname>O'Connell</surname><given-names>M.A.</given-names></name></person-group><article-title>Editing independent effects of ADARs on the miRNA/siRNA pathways</article-title><source>EMBO J.</source><year>2009</year><volume>28</volume><fpage>3145</fpage><lpage>3156</lpage><pub-id pub-id-type="pmid">19713932</pub-id></element-citation></ref><ref id="B29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vesely</surname><given-names>C.</given-names></name><name><surname>Tauber</surname><given-names>S.</given-names></name><name><surname>Sedlazeck</surname><given-names>F.J.</given-names></name><name><surname>von Haeseler</surname><given-names>A.</given-names></name><name><surname>Jantsch</surname><given-names>M.F.</given-names></name></person-group><article-title>Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs</article-title><source>Genome Res.</source><year>2012</year><volume>22</volume><fpage>1468</fpage><lpage>1476</lpage><pub-id pub-id-type="pmid">22310477</pub-id></element-citation></ref><ref id="B30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warf</surname><given-names>M.B.</given-names></name><name><surname>Shepherd</surname><given-names>B.A.</given-names></name><name><surname>Johnson</surname><given-names>W.E.</given-names></name><name><surname>Bass</surname><given-names>B.L.</given-names></name></person-group><article-title>Effects of ADARs on small RNA processing pathways in C. elegans</article-title><source>Genome Res.</source><year>2012</year><volume>22</volume><fpage>1488</fpage><lpage>1498</lpage><pub-id pub-id-type="pmid">22673872</pub-id></element-citation></ref><ref id="B31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>H.</given-names></name><name><surname>Sakurai</surname><given-names>M.</given-names></name><name><surname>Gupta</surname><given-names>R.</given-names></name><name><surname>Valente</surname><given-names>L.</given-names></name><name><surname>Wulff</surname><given-names>B.-E.</given-names></name><name><surname>Ariyoshi</surname><given-names>K.</given-names></name><name><surname>Iizasa</surname><given-names>H.</given-names></name><name><surname>Davuluri</surname></name><name><surname>Ramana</surname><given-names>V.</given-names></name><name><surname>Nishikura</surname><given-names>K.</given-names></name></person-group><article-title>ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing</article-title><source>Cell</source><year>2013</year><volume>153</volume><fpage>575</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">23622242</pub-id></element-citation></ref><ref id="B32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>M.</given-names></name></person-group><source>Cutadapt removes adapter sequences from high-throughput sequencing reads</source><year>2011</year></element-citation></ref><ref id="B33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedlazeck</surname><given-names>F.J.</given-names></name><name><surname>Rescheneder</surname><given-names>P.</given-names></name><name><surname>von Haeseler</surname><given-names>A.</given-names></name></person-group><article-title>NextGenMap: fast and accurate read mapping in highly polymorphic genomes</article-title><source>Bioinformatics</source><year>2013</year><volume>29</volume><fpage>2790</fpage><lpage>2791</lpage><pub-id pub-id-type="pmid">23975764</pub-id></element-citation></ref><ref id="B34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y.</given-names></name><name><surname>Hochberg</surname><given-names>Y.</given-names></name></person-group><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title><source>J. R. Statist. Soc. B</source><year>1995</year><volume>57</volume><fpage>289</fpage><lpage>300</lpage></element-citation></ref><ref id="B35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickins</surname><given-names>R.A.</given-names></name><name><surname>Hemann</surname><given-names>M.T.</given-names></name><name><surname>Zilfou</surname><given-names>J.T.</given-names></name><name><surname>Simpson</surname><given-names>D.R.</given-names></name><name><surname>Ibarra</surname><given-names>I.</given-names></name><name><surname>Hannon</surname><given-names>G.J.</given-names></name><name><surname>Lowe</surname><given-names>S.W.</given-names></name></person-group><article-title>Probing tumor phenotypes using stable and regulated synthetic microRNA precursors</article-title><source>Nat. Genet.</source><year>2005</year><volume>37</volume><fpage>1289</fpage><lpage>1295</lpage><pub-id pub-id-type="pmid">16200064</pub-id></element-citation></ref><ref id="B36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koscianska</surname><given-names>E.</given-names></name><name><surname>Starega-Roslan</surname><given-names>J.</given-names></name><name><surname>Czubala</surname><given-names>K.</given-names></name><name><surname>Krzyzosiak</surname><given-names>W.J.</given-names></name></person-group><article-title>High-resolution northern blot for a reliable analysis of microRNAs and their precursors</article-title><source>ScientificWorldJournal</source><year>2011</year><volume>11</volume><fpage>102</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">21218267</pub-id></element-citation></ref><ref id="B37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozomara</surname><given-names>A.</given-names></name><name><surname>Griffiths-Jones</surname><given-names>S.</given-names></name></person-group><article-title>miRBase: integrating microRNA annotation and deep-sequencing data</article-title><source>Nucleic Acids Res.</source><year>2011</year><volume>39</volume><fpage>D152</fpage><lpage>D157</lpage><pub-id pub-id-type="pmid">21037258</pub-id></element-citation></ref><ref id="B38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>H.R.</given-names></name><name><surname>Schoenfeld</surname><given-names>L.W.</given-names></name><name><surname>Ruby</surname><given-names>J.G.</given-names></name><name><surname>Auyeung</surname><given-names>V.C.</given-names></name><name><surname>Spies</surname><given-names>N.</given-names></name><name><surname>Baek</surname><given-names>D.</given-names></name><name><surname>Johnston</surname><given-names>W.K.</given-names></name><name><surname>Russ</surname><given-names>C.</given-names></name><name><surname>Luo</surname><given-names>S.</given-names></name><name><surname>Babiarz</surname><given-names>J.E.</given-names></name><etal/></person-group><article-title>Mammalian microRNAs: experimental evaluation of novel and previously annotated genes</article-title><source>Genes Dev.</source><year>2010</year><volume>24</volume><fpage>992</fpage><lpage>1009</lpage><pub-id pub-id-type="pmid">20413612</pub-id></element-citation></ref><ref id="B39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.-t.</given-names></name><name><surname>Xu</surname><given-names>S.-d.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>J.-f.</given-names></name><name><surname>Ning</surname><given-names>J.-f.</given-names></name><name><surname>Wang</surname><given-names>S.-f.</given-names></name></person-group><article-title>MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis</article-title><source>Med. Oncol.</source><year>2012</year><volume>29</volume><fpage>1673</fpage><lpage>1680</lpage><pub-id pub-id-type="pmid">22052152</pub-id></element-citation></ref><ref id="B40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>J.</given-names></name><name><surname>Nagai</surname><given-names>T.</given-names></name><name><surname>Furukawa-Hibi</surname><given-names>Y.</given-names></name><name><surname>Kuroda</surname><given-names>K.</given-names></name><name><surname>Kaibuchi</surname><given-names>K.</given-names></name><name><surname>Greenberg</surname><given-names>M.E.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Neuronal Per Arnt Sim (PAS) domain protein 4 (NPAS4) regulates neurite outgrowth and phosphorylation of synapsin I</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>2655</fpage><lpage>2664</lpage><pub-id pub-id-type="pmid">23172225</pub-id></element-citation></ref><ref id="B41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>T.F.</given-names></name><name><surname>Waterman</surname><given-names>M.S.</given-names></name></person-group><article-title>Identification of common molecular subsequences</article-title><source>J. Mol. Biol.</source><year>1981</year><volume>147</volume><fpage>195</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">7265238</pub-id></element-citation></ref><ref id="B42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wahlstedt</surname><given-names>H.</given-names></name><name><surname>Daniel</surname><given-names>C.</given-names></name><name><surname>Enstero</surname><given-names>M.</given-names></name><name><surname>Ohman</surname><given-names>M.</given-names></name></person-group><article-title>Large-scale mRNA sequencing determines global regulation of RNA editing during brain development</article-title><source>Genome Res.</source><year>2009</year><volume>19</volume><fpage>978</fpage><lpage>986</lpage><pub-id pub-id-type="pmid">19420382</pub-id></element-citation></ref><ref id="B43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alon</surname><given-names>S.</given-names></name><name><surname>Mor</surname><given-names>E.</given-names></name><name><surname>Vigneault</surname><given-names>F.</given-names></name><name><surname>Church</surname><given-names>G.M.</given-names></name><name><surname>Locatelli</surname><given-names>F.</given-names></name><name><surname>Galeano</surname><given-names>F.</given-names></name><name><surname>Gallo</surname><given-names>A.</given-names></name><name><surname>Shomron</surname><given-names>N.</given-names></name><name><surname>Eisenberg</surname><given-names>E.</given-names></name></person-group><article-title>Systematic identification of edited microRNAs in the human brain</article-title><source>Genome Res.</source><year>2012</year><volume>22</volume><fpage>1533</fpage><lpage>1540</lpage><pub-id pub-id-type="pmid">22499667</pub-id></element-citation></ref><ref id="B44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S.K.</given-names></name><name><surname>Lazinski</surname><given-names>D.W.</given-names></name></person-group><article-title>Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1</article-title><source>Proc. Natl Acad. Sci. U.S.A.</source><year>2002</year><volume>99</volume><fpage>15118</fpage><lpage>15123</lpage><pub-id pub-id-type="pmid">12399548</pub-id></element-citation></ref><ref id="B45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Yee</surname><given-names>A.J.</given-names></name></person-group><article-title>Versican V2 isoform enhances angiogenesis by regulating endothelial cell activities and fibronectin expression</article-title><source>FEBS Lett.</source><year>2013</year><volume>587</volume><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">23201264</pub-id></element-citation></ref><ref id="B46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname><given-names>K.-H.</given-names></name><name><surname>Brautigan</surname><given-names>P.</given-names></name><name><surname>Hahn</surname><given-names>C.</given-names></name><name><surname>Daish</surname><given-names>T.</given-names></name><name><surname>Rayner</surname><given-names>J.</given-names></name><name><surname>Cheah</surname><given-names>P.-S.</given-names></name><name><surname>Raison</surname><given-names>J.</given-names></name><name><surname>Piltz</surname><given-names>S.</given-names></name><name><surname>Mann</surname><given-names>J.</given-names></name><name><surname>Mattiske</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Deep sequencing analysis of the developing mouse brain reveals a novel microRNA</article-title><source>BMC Genomics</source><year>2011</year><volume>12</volume><fpage>176</fpage><pub-id pub-id-type="pmid">21466694</pub-id></element-citation></ref><ref id="B47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabas-Madrid</surname><given-names>D.</given-names></name><name><surname>Nogales-Cadenas</surname><given-names>R.</given-names></name><name><surname>Pascual-Montano</surname><given-names>A.</given-names></name></person-group><article-title>GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics</article-title><source>Nucleic Acids Res.</source><year>2012</year><volume>40</volume><fpage>W478</fpage><lpage>W483</lpage><pub-id pub-id-type="pmid">22573175</pub-id></element-citation></ref><ref id="B48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogales-Cadenas</surname><given-names>R.</given-names></name><name><surname>Carmona-Saez</surname><given-names>P.</given-names></name><name><surname>Vazquez</surname><given-names>M.</given-names></name><name><surname>Vicente</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Tirado</surname><given-names>F.</given-names></name><name><surname>Carazo</surname><given-names>J.M.</given-names></name><name><surname>Pascual-Montano</surname><given-names>A.</given-names></name></person-group><article-title>GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information</article-title><source>Nucleic Acids Res.</source><year>2009</year><volume>37</volume><fpage>W317</fpage><lpage>W322</lpage><pub-id pub-id-type="pmid">19465387</pub-id></element-citation></ref><ref id="B49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmona-Saez</surname><given-names>P.</given-names></name><name><surname>Chagoyen</surname><given-names>M.</given-names></name><name><surname>Tirado</surname><given-names>F.</given-names></name><name><surname>Carazo</surname><given-names>J.</given-names></name><name><surname>Pascual-Montano</surname><given-names>A.</given-names></name></person-group><article-title>GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists</article-title><source>Genome Biol.</source><year>2007</year><volume>8</volume><fpage>R3</fpage><pub-id pub-id-type="pmid">17204154</pub-id></element-citation></ref><ref id="B50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuker</surname><given-names>M.</given-names></name></person-group><article-title>Mfold web server for nucleic acid folding and hybridization prediction</article-title><source>Nucleic Acids Res.</source><year>2003</year><volume>31</volume><fpage>3406</fpage><lpage>3415</lpage><pub-id pub-id-type="pmid">12824337</pub-id></element-citation></ref><ref id="B51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huasong</surname><given-names>G.</given-names></name><name><surname>Zongmei</surname><given-names>D.</given-names></name><name><surname>Jianfeng</surname><given-names>H.</given-names></name><name><surname>Xiaojun</surname><given-names>Q.</given-names></name><name><surname>Jun</surname><given-names>G.</given-names></name><name><surname>Sun</surname><given-names>G.</given-names></name><name><surname>Yan</surname><given-names>W.</given-names></name><name><surname>Donglin</surname><given-names>W.</given-names></name><name><surname>Jianhong</surname><given-names>Z.</given-names></name></person-group><article-title>Serine protease inhibitor (SERPIN) B1 suppresses cell migration and invasion in glioma cells</article-title><source>Brain Res.</source><year>2014</year><comment>doi:10.1016/j.brainres.2014.06.017</comment></element-citation></ref><ref id="B52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>K.-J.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Hamblin</surname><given-names>M.</given-names></name><name><surname>Xie</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Y.E.</given-names></name></person-group><article-title>miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia</article-title><source>Neurobiol. Dis.</source><year>2010</year><volume>38</volume><fpage>17</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">20053374</pub-id></element-citation></ref><ref id="B53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>S.</given-names></name><name><surname>Pandey</surname><given-names>A.</given-names></name><name><surname>Shukla</surname><given-names>A.</given-names></name><name><surname>Talwelkar</surname><given-names>S.S.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Pant</surname><given-names>A.B.</given-names></name><name><surname>Parmar</surname><given-names>D.</given-names></name></person-group><article-title>miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>37347</fpage><lpage>37357</lpage><pub-id pub-id-type="pmid">21878650</pub-id></element-citation></ref><ref id="B54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eggington</surname><given-names>J.M.</given-names></name><name><surname>Greene</surname><given-names>T.</given-names></name><name><surname>Bass</surname><given-names>B.L.</given-names></name></person-group><article-title>Predicting sites of ADAR editing in double-stranded RNA</article-title><source>Nat. Commun.</source><year>2011</year><volume>2</volume><fpage>319</fpage><pub-id pub-id-type="pmid">21587236</pub-id></element-citation></ref><ref id="B55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S.K.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name><name><surname>Lazinski</surname><given-names>D.W.</given-names></name></person-group><article-title>Substrate recognition by ADAR1 and ADAR2</article-title><source>RNA</source><year>2001</year><volume>7</volume><fpage>846</fpage><lpage>858</lpage><pub-id pub-id-type="pmid">11421361</pub-id></element-citation></ref><ref id="B56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname><given-names>O.</given-names></name><name><surname>Oren</surname><given-names>S.</given-names></name><name><surname>Safran</surname><given-names>M.</given-names></name><name><surname>Deshet-Unger</surname><given-names>N.</given-names></name><name><surname>Akiva</surname><given-names>P.</given-names></name><name><surname>Jacob-Hirsch</surname><given-names>J.</given-names></name><name><surname>Cesarkas</surname><given-names>K.</given-names></name><name><surname>Kabesa</surname><given-names>R.</given-names></name><name><surname>Amariglio</surname><given-names>N.</given-names></name><name><surname>Unger</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR)</article-title><source>RNA</source><year>2013</year><volume>19</volume><fpage>591</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">23474544</pub-id></element-citation></ref><ref id="B57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chawla</surname><given-names>G.</given-names></name><name><surname>Sokol</surname><given-names>N.S.</given-names></name></person-group><article-title>ADAR mediates differential expression of polycistronic microRNAs</article-title><source>Nucleic Acids Res.</source><year>2014</year><volume>42</volume><fpage>5245</fpage><lpage>5255</lpage><pub-id pub-id-type="pmid">24561617</pub-id></element-citation></ref><ref id="B58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahn</surname><given-names>J.H.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Greer</surname><given-names>C.</given-names></name><name><surname>Peng</surname><given-names>G.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name></person-group><article-title>Accurate identification of A-to-I RNA editing in human by transcriptome sequencing</article-title><source>Genome Res.</source><year>2012</year><volume>22</volume><fpage>142</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">21960545</pub-id></element-citation></ref><ref id="B59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Z.</given-names></name><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Tan</surname><given-names>B.C.</given-names></name><name><surname>Kang</surname><given-names>L.</given-names></name><name><surname>Tian</surname><given-names>Z.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Liang</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Tan</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome</article-title><source>Nat. Biotechnol.</source><year>2012</year><volume>30</volume><fpage>253</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">22327324</pub-id></element-citation></ref><ref id="B60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>J.</given-names></name><name><surname>Goodman</surname><given-names>R.A.</given-names></name><name><surname>Schirle</surname><given-names>N.T.</given-names></name><name><surname>David</surname><given-names>S.S.</given-names></name><name><surname>Beal</surname><given-names>P.A.</given-names></name></person-group><article-title>RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1</article-title><source>Proc. Natl Acad. Sci. U.S.A.</source><year>2010</year><volume>107</volume><fpage>20715</fpage><lpage>20719</lpage><pub-id pub-id-type="pmid">21068368</pub-id></element-citation></ref></ref-list></back></article>